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Abstract 
Divergent neural pathways emanating from the lateral parabrachial nucleus mediate 
distinct components of the pain response 
 
Michael C. Chiang, PhD 
 
University of Pittsburgh, 2019 
 
 
 
 
The lateral parabrachial nucleus (lPBN) is a major target of spinal projection neurons 
conveying nociceptive input into supraspinal structures. However, the functional role of distinct 
lPBN efferents for diverse nocifensive responses have remained largely uncharacterized. Here, we 
show that two populations of efferent neurons from different regions of the lPBN collateralize to 
distinct targets. Activation of efferent projections to the ventromedial hypothalamus (VMH) or 
lateral periaqueductal gray (lPAG) drive escape behaviors, whereas the activation of lPBN 
efferents to the bed nucleus stria terminalis (BNST) or central amygdala (CEA) generates an 
aversive memory. Finally, we provide evidence that dynorphin expressing neurons span 
cytoarchitecturally distinct domains of the lPBN to coordinate these distinct aspects of the 
nocifensive response.  
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1.0 Introduction 
1.1 The parabrachial nucleus: an overview of its function and connectivity 
Noxious stimuli drive innate behaviors that promote an animal’s immediate and long-term 
survival from these potentially life-threatening events. Unpleasant temperatures, food, and 
cutaneous sensations elicit avoidance behavior. In the presence of potentially threatening odors or 
visual cues, an animal becomes more aroused and primed for “fight or flight”. Tissue damage 
drives escape behaviors and a memory of such events. Regardless of the modality of these stimuli, 
hardwired neural connections permit appropriate physiological responses that begin with adaptive 
autonomic changes which are followed by the emergence of learned avoidance behavior. These 
neural circuits encode stereotyped behavioral sequences that shift toward more complex motor 
actions as the severity of potential damage increases. For example, low intensity noxious stimuli 
drive withdrawal reflexes, whereas high intensity noxious stimuli recruit escape behaviors. 
Together, these distinct behavioral responses form a nocifensive response (Browne et al., 2017; 
Espejo and Mir, 1993; Fan et al., 1995; Le Bars et al., 2001). Despite the importance of the 
appropriate response for survival, the neural underpinnings of the distinct components that make 
up the nocifensive response remain to be fully explored. A growing body of work points to the 
significant contributions of the parabrachial complex (PBN), an evolutionarily conserved 
hindbrain structure in mammalian species that orchestrates behavioral outputs with autonomic 
changes to these threats.  
The PBN is located in the pons at the junction between midbrain and hindbrain and 
comprises more than a dozen subnuclei that surround the superior cerebellar peduncles, fiber tracts 
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that communicate between deep cerebellar and midbrain nuclei. The neurons within these 
cytoarchitecturally distinct subdivisions express neuropeptides and chemical markers that both 
neurochemically and functionally distinguish them. Furthermore, the inputs into PBN and its 
subregions can also be categorized in this way. Such differential expression patterns may underlie 
how the PBN, through its anatomical organization, integrates incoming information to elicit a 
coordinated behavioral response through its projections to forebrain targets. Here, we provide an 
overview of its anatomical organization and functional connectivity in response to diverse sensory 
modalities. 
1.2 Parabrachial cell morphology 
The PBN complex has been cytoarchitecturally categorized based upon the morphology of 
the subpopulations of neurons within each subdivision of the PBN complex. Medial PBN (mPBN) 
comprises populations of neurons heterogeneous in size and morphology, unlike those within the 
lateral PBN (lPBN), which comprise several homogeneous groups (Fulwiler and Saper, 1984; 
Saper and Loewy, 1980). Whereas the dendritic domains of mPBN neurons have been less 
extensively characterized, those of the lateral PBN (lPBN) can be categorized into one of several 
groups: those that remain confined within subnuclear domains, those that extend into neighboring 
lPBN subnuclei, and those that project to other brain regions (Herbert and Bellintani-Guardia, 
1995). Despite extensive morphometric and anatomical analysis of the cells, the identities of pre- 
and post-synaptic lPBN cells within these local microcircuits remains to be fully characterized. 
Nevertheless, these studies support the idea that cells within both mPBN and lPBN serve as 
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integrators of both interoceptive and exteroceptive signals to elicit a coordinated behavioral action 
through its connections with downstream targets.  
1.3 Anatomical organization of the parabrachial nucleus 
1.3.1  Afferent projections 
The afferent and efferent connections in the PBN complex have been well-characterized in 
rigorous detail. Numerous ascending and descending pathways converge onto the PBN complex 
that contribute to the regulation of autonomic responses to interoceptive and exteroceptive signals. 
Sensory input regarding taste, visceral information, fluid balance, and cardiovascular function 
arise from the area postrema and nucleus of the solitary tract (NTS) and terminate in discrete 
patterns that map to the dendritic domains and subnuclear boundaries of the lPBN (Cechetto and 
Calaresu, 1985; Feil and Herbert, 1995; Herbert et al., 1990). The NTS, retrotrapezoid nucleus in 
the rostral medulla of the brainstem, and Kölliker-Fuse nucleus neighboring the PB complex also 
convey chemosensory signals to lPBN to regulate respiration and hypercapnic arousal (Kaur et al., 
2013; Kaur et al., 2017). 
Nociceptive, pruritic, and thermal input also reach the PB complex through 
spinoparabrachial neurons within lamina I of the dorsal horn spinal cord. These projection neurons 
express the neurochemical marker neurokinin-1 receptor and densely innervate dorsal divisions of 
the PB complex, primarily the internal, central, and dorsal subnuclei (Cameron et al., 2015; 
Harrison et al., 2004; Hylden et al., 1989). The spinal trigeminal nucleus carrying nociceptive 
information related to the craniofacial structures projects primarily to the external lateral division 
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of the PBN (Feil and Herbert, 1995; Rodriguez et al., 2017)The rostroventral medulla (RVM) also 
projects to the lPBN. Although these connections have primarily been characterized as mediating 
cardiovascular and respiratory input, a subpopulation RVM neurons expressing Tac1 has recently 
been demonstrated to be involved in mediating nocifensive responses to noxious heat (Barik et al., 
2018) 
1.3.2  Efferent projections 
The PBN complex comprises multiple subnuclei with reciprocal connections with its inputs 
and whose outputs are also organized topographically (Fulwiler and Saper, 1984; Moga et al., 
1990; Saper and Loewy, 1980; Tokita et al., 2009). Its vast connectivity with forebrain and 
brainstem structures highlights its critical involvement in integrating sensory information with 
brain regions that regulate autonomic functions in response to gustation, consummatory behavior, 
pain, itch, thermoregulation, respiratory control, and cardiovascular regulation (Benarroch, 2016, 
2018; Davern, 2014; Kaur and Saper, 2019). Efferent projections to insula arise primarily from 
mPBN and the ventral lPBN. The bed nucleus of the stria terminalis and central amygdala also 
receive dense innervation from lPBN subnuclei, with the greatest number of inputs arising from 
elPBN. Efferents to hypothalamic regions arise primarily from mPBN and rostral lPBN, mainly 
the superior lateral and dorsal divisions, and innervate the preoptic area, anteroventral 
periventricular, paraventricular, dorsal medial, ventromedial, and lateral hypothalamic nuclei. 
Thalamic inputs to paraventricular thalamus and thalamic nuclei (ventral posterior, ventral medial, 
intralaminar, and centromedial) also arise from mPBN and generally rostral lPBN subdivisions 
(central, internal, and dorsal lPBN). Brainstem projections to NTS and rostral medulla arise from 
the ventrolateral aspect of the lPBN. Advances in techniques and the emergence of genetically 
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engineered mice to target distinct lPBN subnuclei have enabled more detailed characterizations of 
PBN circuitry and their involvement in behavioral responses to threats and aversive stimuli. 
1.4 Physiological properties of parabrachial neurons 
In line with the multiple distinct subnuclei of the lPBN, the neural populations within these 
subdivisions appear to have somewhat different electrophysiological properties. Compared to the 
elPBN, neurons within more dorsal divisions exhibited less spike frequency adaptation (Hayward 
and Felder, 1999). A separate study identified additional differences in membrane resistance and 
time constant, action potential duration, firing frequency, and action potential latency among 
separate dPBN subnuclei (Kobashi and Bradley, 1998). How these properties relate to different 
genetically-defined classes of lPBN neurons and their functional contributions remain an area of 
active investigation. 
1.5 Neurochemical and functional characterizations of parabrachial  
As prior studies have revealed, the lPBN comprises cytoarchitecturally distinct divisions 
with distinct projection patterns, suggesting the possibility of functional segregation of different 
genetically defined neural populations. Some subdomains uniquely express a number of 
neuropeptides, whereas other neurochemical markers appear to be broadly expressed (Block and 
Hoffman, 1987; Miller et al., 2012; Zagami and Stifani, 2010). Somatostatin, enkephalin, and 
vasoactive intestinal peptide were observed to be mostly robustly expressed in dPBN. Neurotensin 
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was found to be most abundantly expressed in more rostral dPBN. Cholecystokinin expression 
was also in dPBN, specifically the superiolateral division. Tyrosine hydroxylase-positive cells 
were found scattered throughout dPBN. 
The advances in mouse genetics have allowed for the generation of powerful gene-
targeting technology that enables cell-type specific neural manipulations from a heterogeneous 
mix. Although the number of genetically-defined populations within the lPBN have yet to be fully 
characterized, a number of Cre-driver mouse lines have been developed to permit the visualization 
and functional characterization of distinct subpopulations. An overview of the current 
understanding of these lPBN subsets is provided. 
 
SatB2 neurons and electrophysiological evidence for taste 
Sensory neurons relay different modalities of taste to the nucleus solitary tract and 
subsequently into the parabrachial nucleus (Carleton et al., 2010). Electrophysiological recordings 
have demonstrated a topographic response to different tastants: bitter or generally unpleasant tastes 
activate elPBN, whereas sweet tastants preferentially promote Fos expression in dPBN (Tokita 
and Boughter, 2016; Yamamoto et al., 1994; Yamamoto et al., 2009). Only recently has the 
molecular identity of a gustatory neural population in the central nervous system been implicated 
in a particular taste modality, that is for sweet taste. SatB2-expressing neurons occur in the waist 
region of the parabrachial complex that bridges the superior cerebellar peduncle between the 
medial and lateral PBN. A recent study found that ablating this population resulted in significantly 
diminished taste preference for sucrose without effecting preference for umami, bitter, sour, or 
salty (Fu et al., 2019). Furthermore, activating SatB2-expressing projections to ventral 
posteromedial thalamus enhanced appetitive behavior and promoted real time place preference to 
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light stimulation, suggesting this specific output encodes positive valence to consummatory 
behavior. Identifying additional genetically-defined lPBN populations that respond preferentially 
to other taste modalities would provide greater insight into gustatory coding in the lPBN. 
Cholecystokinin, leptin receptor and glucose homeostasis 
The central circuits that mediate glucose homeostasis involve lPBN neurons expressing 
cholecystokinin (CCK) (Garfield et al., 2014). These neurons are expressed throughout lPBN, with 
the majority located in dorsal divisions of lPBN. Hypoglycemia drives Fos expression in these 
neurons, which consequently signal to downstream VMH neurons expressing steroidogenic-factor 
1 (SF-1) to drive an autonomically mediated counterregulatory response to increase glucose 
production. Moreover, CCK-positive lPBN neurons coexpress the leptin receptor. Administration 
of leptin into the lPBN resulted in impaired hyperglycemic response, and genetic deletion of leptin 
receptor for CCK lPBN neurons enhanced the counterregulatory response (Flak et al., 2014). The 
neural circuitry that CCK-expressing neurons engage underlie physiological adaptations that 
require enhanced glucose production and mobilization. Consistent with this idea, activating SF-1 
VMH neurons robustly elicits both overt defensive-like behaviors characterized by running, 
jumping, and some freezing in addition to autonomic changes in respiratory rate, heart rate, and 
pupil size (Wang et al., 2015). Thus the increase in glucose production may fuel the metabolic 
needs for the animal to engage in these escape-like behaviors. Furthermore, activating PAG 
neurons expressing the leptin receptor promoted hyperglycemia, whereas genetically ablating 
leptin receptor from these neurons also increased glucose production in response to noxious stimuli 
(Flak et al., 2017). Together, the CCK-positive subset of lPBN neurons integrates sensory signals, 
such as noxious input or hunger, to facilitate appropriate autonomic and behavioral responses that 
require glucose mobilization. 
 8 
lPBN and feeding 
Different lPBN subpopulations encode either positive and negative valences to feeding. An 
unknown dPBN population receives input from melanocortin-4 receptor (MC4R) paraventricular 
hypothalamus neurons to mediate positive valence and satiety in food-deprived mice (Garfield et 
al., 2015). However, gustatory neurons that express either CCK or noradrenergic, dopamine β-
hydroxylase (DBH) form monosynaptic connections with CGRP elPBN neurons that suppress 
food intake (Campos et al., 2016; Roman et al., 2016). Both the CGRP and dPBN neurons 
downstream of MC4R-positive PVH neurons appear to be distinct, nonoverlapping populations. 
Their differential activity, and potentially interactions among each other and other unknown lPBN 
populations, regulate food consumption. 
 
Oxytocin receptor and fluid satiety 
Parabrachial neurons have been implicated in regulating fluid homeostasis (Geerling and 
Loewy, 2008; Menani et al., 2014). Whereas some lPBN neurons drive salt intake in hyponatremic 
mice (Geerling and Loewy, 2007; Jarvie and Palmiter, 2017), those that express the oxytocin 
receptor (Oxtr) specifically regulate hypernatremia and hypervolemia regardless of food and salt 
deprivation (Ryan et al., 2017). Chemogenetic activation of these neurons reduces non-caloric 
fluid intake in dehydrated mice, whereas inhibition promotes the opposite effect. Oxtr-positive 
lPBN neurons are regulated through multiple pathways. Although many brain regions express and 
use oxytocin for different physiological purposes (Lee et al., 2009), those within the 
paraventricular nucleus of the hypothalamus lie upstream of Oxtr-positive lPBN neurons and 
moderately regulate their activity. On the other hand, inputs from the nucleus of the solitary tract 
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strongly reduce fluid intake likely through the recruitment of multiple lPBN subpopulations that 
indirectly drive Oxtr-expressing lPBN neurons. 
Dynorphin, FoxP2, and thermal homeostasis 
A subset of excitatory dPBN neurons express the neuropeptide dynorphin and have been 
found to respond to warm ambient temperature (Geerling et al., 2016). Furthermore, these neurons 
project to numerous forebrain regions that govern thermosensation (Allen brain institute 
Experiment: 543876073, http://connectivity.brain-map.org/). Consistent with a role in 
thermoregulation, dorsal horn neurons carrying thermal information innervate dPBN within the 
subdivisions of dynorphin-expressing neurons. In turn, these distinct lPBN divisions project to the 
preoptic area of the anterior hypothalamus to mediate autonomic responses that maintain thermal 
homeostasis (Nakamura and Morrison, 2008, 2010; Tan and Knight, 2018). Additional studies are 
warranted to confirm whether dynorphin-positive neurons indeed contribute to thermoregulation 
in response to warm temperature. In addition, a broad excitatory population of neurons within 
lPBN express the transcription factor and neurochemical marker FoxP2 (forkhead box protein P2). 
However, only a subset of FoxP2-expressing neurons within the elPBN respond strongly to cold 
ambient temperature (Geerling et al., 2016). Thus, two non-overlapping populations within the 
lPBN may be mediating the thermoregulatory response to warm or cold temperatures. 
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Glutamatergic lPBN neurons and itch 
Although the lPBN responds to pruriceptive stimuli (Jansen and Giesler, 2015), a specific 
genetically-defined subset of lPBN neurons has yet to be attributed to this sensory modality. 
Rather, glutamatergic lPBN neurons, which make up the majority of lPBN (Guthmann et al., 1998; 
Yokota et al., 2007), have been found to be important mediators of itch. Optogenetic or 
chemogenetic inhibition of lPBN, as well as genetic deletion of Vglut2 from lPBN neurons, 
resulted in decreased scratching in response to a pruritogen such as chloroquine (Mu et al., 2017). 
A separate study found that silencing glutamatergic neurotransmission in CGRP-expressing 
neurons also attenuated scratching to chloroquine and non-chemical stimuli (Campos et al., 2018). 
Interestingly, chemogenetic inhibition or genetic deletion of Vglut2 had no effect on acute 
mechanical and thermal hypersensitivity (Mu et al., 2017). Additional experiments will be needed 
to confirm these findings. 
lPBN contributions to pain affect 
lPBN has been demonstrated to serve an important role in receiving, processing, and 
relaying somatic and visceral nociceptive signals (Bernard and Besson, 1990; Bernard et al., 1994; 
Bourgeais et al., 2001; Buritova et al., 1998; Campos et al., 2018; Gauriau and Bernard, 2002a, b; 
Hermanson and Blomqvist, 1996). In animal models the lPBN is one of two major supraspinal 
targets of the anterolateral tract (Cameron et al., 2015; Cechetto et al., 1985; Hylden et al., 1989; 
Polgar et al., 2010; Todd, 2010). Although the lPBN responds to different noxious modalities 
(chemical, thermal, and mechanical), the elPBN neurons have been attributed to the affective 
dimensions of pain via its connections to amygdalar targets (This population expresses CGRP, 
which will be discussed in following paragraph) (Bernard and Besson, 1990; Gauriau and Bernard, 
2002a; Han et al., 2015a; Jasmin et al., 1997). Recent work has implicated a nociceptive trigemino-
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parabrachial pathway onto CGRP-expressing elPBN neurons in which its activation induces stress 
vocalization and avoidance behavior, while its inhibition reduces inflammatory facial pain via 
capsaicin-induced mechanical hypersensitivity of the whisker pads (Rodriguez et al., 2017).  
NPY1R and hunger as a competing behavioral state to reduce inflammatory pain 
The lPBN serves as an integrator of different physiological states to govern appropriate 
adaptive behaviors to different environmental challenges, for example between hunger and pain 
(Malick et al., 2001). A recent study identified a neural mechanism through which the lPBN 
prioritizes these competing needs. Food-deprived mice exhibit diminutions in the negative valence 
associated with and the behavioral response to hindpaw formalin administration, a model of 
inflammatory pain (Alhadeff et al., 2018). However, acute pain response remained unaffected. 
This competing state arises from the increased activity of GABAergic inputs from agouti-related 
peptide (AgRP) neurons in the arcuate nucleus neurons following 24-hour fasting. In the presence 
of an acute painful stimulus, the activity of these neurons decreases. Microinjections of GABA 
antagonists into lPBN failed to reverse the nocifensive licking response to intraplantar formalin. 
Rather, the release of neuropeptide Y (NPY) from AgRP-positive afferents onto lPBN neurons 
expressing the NPY1 receptor (NPY1R) suppressed the inflammatory nocifensive response to 
intraplantar formalin. The degree in which NPY1R neurons overlap with CGRP-expressing 
neurons would warrant future investigations, as the activity of these neurons encode negative 
valence and promote aversive behaviors (Campos et al., 2018). 
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Tachykinin1 and nocifensive behavior 
A recent study identified an lPBN population expressing tachykinin 1 (Tac1). Tac1-
positive lPBN neurons are primarily within the elPBN with a sparsely distributed population 
throughout dPBN (Barik et al., 2018). Those in elPBN partially overlap with CGRP-positive 
neurons and project to similar forebrain structures. However, Barik et al. revealed a unique subset 
of Tac1 neurons that project to RVM. Chemogenetic activation of this population resulted in 
enhanced nocifensive response to noxious heat as measured by increased jumping. Importantly, 
they noted no jumping without this noxious stimulus, and this motor response occurred 
independent of forebrain involvement. How Tac1 neurons projecting to these forebrain targets 
contribute to other stereotyped motor responses to noxious stimuli remain to be determined. 
Pituitary adenylate cyclase activating polypeptide, anxiety, and pain 
Pituitary adenylate cyclase activating polypeptide (PACAP) signaling through its cognate 
receptor PAC 1 has been implicated in nociception. PACAP deficient mice or PAC 1 receptor KO 
mice exhibit dramatic decreases in persistent pain responses (Jongsma et al., 2001; Mabuchi et al., 
2004). However, it is important to note that expression of PACAP and PAC 1 occur broadly 
throughout the peripheral and central nervous systems (Mulder et al., 1994; Zhang et al., 1995). 
Within brain, and particularly the lPBN, PACAP expression appears localized to the elPBN. 
Consistent with this, its projection pattern overlaps with those of the CGRP-expressing population 
by approximately 60 – 70%, and excitotoxic lesions of lPBN results in significant loss of both 
PACAP and CGRP immunoreactive fibers in CEA and BNST (Missig et al., 2014). Interestingly, 
PACAP appears to be broadly upregulated in lPBN neurons following the chronic constriction 
injury (CCI) model of neuropathic pain (Missig et al., 2017), suggesting functional expression of 
PACAP correlated with neuroplasticity. PACAP infusions into CEA increased anxiety-like 
 13 
behaviors and thermal hypersensitivity, whereas the PACAP receptor 1 antagonist PACAP (6-38) 
attenuated the CCI-mediated behavioral effects. These experiments demonstrate the contributions 
of parabrachial-amygdalar PACAP signaling on different measures of pain behavior and suggest 
a neural substrate through which the development of chronic pain and stress-related comorbidities 
arise (Scioli-Salter et al., 2015). 
lPBN signaling on cardiovascular response 
The nucleus of the solitary tract and brainstem nuclei transmit signals related to blood 
pressure, aortic stretch, and carotid chemoreceptors to the lPBN (Benarroch, 2018; Davern, 2014; 
Jhamandas et al., 1991). However, the genetic identity of lPBN neurons underlying cardiovascular 
responses remains unclear, although they have been found to be primarily excitatory (Guo et al., 
2005). Electrical and glutamate stimulation of different lPBN subdivisions resulted in opposing 
effects: elPBN activation caused tachycardia whereas dlPBN appeared to drive depressor 
bradycardic changes (Chamberlin and Saper, 1992).  
Calcitonin gene-related peptide and arousal from hypercapnia 
Stimulating lPBN neurons results in increased cortical arousal thought to be mediated 
through its connections with forebrain structures (Luo et al., 2018; Qiu et al., 2016). In line with 
these studies, genetic deletion of glutamatergic signaling decreases arousal states and reduces 
cortical activity (Kaur et al., 2013). Recently, a study found that the CGRP-expressing population 
serves critical roles in mediating cortical arousal, at least in response to hypercapnia (Kaur et al., 
2017). Stimulating these neurons decreases the latency to arousal and increases wakefulness states 
during hypercapnia. Inhibiting these neurons prevented hypercapnia-induced arousal. Moreover, 
inhibiting projections of CGRP-positive lPBN neurons to forebrain structures (CEA, BNST, and 
LH) all increased arousal latency to hypercapnia. These suggest redundant pathways that underlie 
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a critical physiological and behavioral response to a life-threatening stimulus. Still, differences 
were observed between the latency to which terminal inhibition of these projections delayed 
arousal latency, leaving open the possibility of subtle differences in the functional significance in 
these different ascending pathways that increase cortical arousal. 
Calcitonin gene-related peptide signaling as a general alarm 
As described in the preceding paragraphs, the CGRP-expressing elPBN population has 
been attributed to diverse physiological and behavioral roles, suggesting that these neurons 
respond more broadly to a wide range of sensory signals (Palmiter, 2018; Saper, 2016). Indeed, a 
recent study found that elPBN CGRP neurons respond to multiple different stimuli that may be of 
potential harm – visceral and cutaneous noxious input (chemical, mechanical, thermal, and 
electrical) in addition to environmental stimuli such as novelty and fear learning (Campos et al., 
2018). These neurons seem to encode negative valence because blocking glutamatergic release 
resulted in decreased behavioral responses to unpleasant or potentially harmful stimuli (reduction 
in chloroquine-induced scratching, increased novel food intake, and attenuated conditioning to 
aversive signals) (Campos et al., 2018; Carter et al., 2015; Chen et al., 2018; Han et al., 2015b; 
Palmiter, 2018). How CGRP-expressing elPBN neurons orchestrate these diverse behavioral and 
physiological responses remains a topic of exploration.  
1.6 Summary 
The wide range of sensory information that converges onto the lPBN underscores the 
diversity of lPBN neurons involved in responding to different sensory modalities. Furthermore, it 
emphasizes the clinical significance of lPBN signaling in different pathophysiological states in 
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human diseases. For example, circuit dysfunction involving the CGRP-expressing population may 
have significant implications in the manifestation of a wide range of human disorders such as 
chronic pain, anorexia, and generalized anxiety. Given the diverse roles of lPBN, understanding 
the functional contributions of even a single genetically-defined subpopulation is a huge endeavor. 
Instead, we focused our efforts on understanding lPBN contributions to one of its many 
physiological roles – that is, how lPBN orchestrates behavioral responses to pain. In Chapter 2, we 
characterize the unique anatomical traits of different lPBN subnuclei. Consequently, we designed 
experiments aimed to elucidate the role of different subregions of lPBN and their anatomical 
connections to downstream targets on the nocifensive response in Chapter 3. Through our 
investigations we identified a unique subpopulation of lPBN neurons expressing dynorphin, which 
we hypothesize coordinates nocifensive responses detailed in Chapter 4. Finally, we speculate 
more broadly about how these lPBN efferent pathways underlie different aspects of homeostastic 
regulation of different sensory modalities. 
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2.0 Lateral parabrachial nucleus circuitry and activity in the pain response 
2.1  Introduction 
The lPBN is a major downstream target of spinoparabrachial neurons that conveys noxious 
signals into supraspinal structures, and previous work has demonstrated lPBN involvement in 
responses to these inputs. However, most have studied the excitatory population expressing the 
vesicular glutamate transporter 2 (Vglut2), as they compose the majority of neurons within lPBN. 
(Geerling et al., 2017; Guthmann et al., 1998; Yokota et al., 2007). In this chapter we describe 
experiments that determine the significance of the lPBN in the pain response. To get at this, we 
target a subset of inhibitory lPBN neurons expressing Gad2 that have not been thoroughly 
explored. These data lead us to consequently perform a series of experiments that characterize in 
further detail the anatomical projections of lPBN outputs, which we believe are also primarily 
excitatory. Given the cytoarchitecturally distinct divisions of lPBN, we predict that these regions 
exhibit unique projection patterns that potentially regulate different physiological and behavioral 
responses. 
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2.2 Methods 
2.2.1  Animals 
Mice were given free access to food and water and housed under standard laboratory 
conditions. The use of animals was approved by the Institutional Animal Care and Use Committee 
of the University of Pittsburgh. Gad2-IRES-Cre (Taniguchi et al., 2011), Ai34 (RCL-Syp/tdT)-D, 
and Rosa26 CAG-LSL- ReaChR-mCit (Hooks et al., 2015) were obtained from Jackson 
Laboratory. Wild-type C57BL/6 mice were obtained from Charles River (Cat # 027). For all 
experiments 8 – 16 week-old male and female mice were used. In all cases, no differences between 
male and female mice were observed and so the data were pooled. Age-matched littermates were 
used for all behavioral experiments that involved mice harboring the knock-in allele Cre-
recombinase.  
2.2.2  Viruses 
The following viruses were used for experimentation: AAV2-EF1a-DIO-eYFP (Addgene: 
27056), AAV2-EF1a-DIO-hChR2(H134R)-eYFP (Addgene: 20298), and AAV2-CMV-CreGFP 
(Addgene 49056). Viruses were purchased from University of North Carolina Vector Core and 
University of Pennsylvania Vector Core. 
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2.2.3  Stereotaxic injections and optical fiber implantation 
Animals were anesthetized with 2% isoflurane and placed in a stereotaxic head frame. 
Ophthalmic ointment was applied to the eyes. The scalp was shaved, local antiseptic applied 
(betadine), and a midline incision made to expose the cranium. The skull was aligned using cranial 
fissures. A drill bit (MA Ford, #87) was used to create a burr hole and custom-made metal needle 
(33 gauge) loaded with virus was subsequently inserted through the hole to the injection site. Virus 
was infused at a rate of 100 nL/min using a Hamilton syringe with a microsyringe pump (World 
Precision Instruments). Gad2Cre mice were bilaterally injected with 0.5 l virus. The injection 
needle was left in place for an additional 5- 10 min and then slowly withdrawn. Injections and 
optical fiber implantations were performed bilaterally at the following coordinates for each brain 
region: BNST: AP +0.50 mm, ML ± 1.00 mm, DV -4.30; CEA: AP -1.20 mm, ML ± 2.85 mm, 
DV -4.50; VMH: AP -1.48 mm ML ± -0.50 mm DV -5.80 mm; lPAG: AP -4.70 mm, ML ± 0.74 
mm, DV: -2.75; and lPBN AP -5.11 mm, ML ± 1.25 mm, DV: -3.25. For implantation of optical 
fibers (Thor Labs: 1.25 mm ceramic ferrule 230 m diameter), implants were slowly lowered 
0.300-0.500 mm above the site of injection and secured to the skull with a thin layer of Vetbond 
(3M) and dental cement. The incision was closed using Vetbond and animals were given a 
subcutaneous injection of buprenorphine (0.3 mg/kg) and allowed to recover over a heat pad. Mice 
were given 4 weeks to recover prior to experimentation. 
2.2.4  CTB backlabeling 
Fluorescently conjugated cholera toxin subunit B-Alexa-fluor conjugates -555 and -647 
(CTB, ThermoFisher C34778, C22843) were stereotactically injected (0.2 l, 1 mg/ml) into the 
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brain regions of interest and subsequently analyzed 10 days following injection. Mice were 
perfused and brains were processed as described above for immunohistochemistry. CTB-labeled 
cells were quantified using 65 m z-stacked images at 2 m steps of the entire lPBN (n = 3 – 5 
mice per backlabeled region). For retrograde labeling of cells and quantification of pre- and post- 
synaptic markers, 3 – 4 40 m sections were quantified for a given animal, and 4 mice were used 
per experiment.  
2.2.5  Immunohistochemistry 
Mice were anesthetized with an intraperitoneal injection of urethane, transcardially 
perfused, and post-fixed at least four hours in 4% paraformaldehyde. 40 or 65 m thick transverse 
brain or spinal cord sections were collected on a vibratome and processed free-floating for 
immunohistochemistry. Sections were blocked at room temperature for two hours in a 10% donkey 
serum, 0.1% triton, 0.3M NaCl in phosphate buffered saline. Primary antisera was incubated for 
14 hours overnight at 4°C: chicken anti-GFP (1:1K). Sections were subsequently washed three 
times for 20 minutes in wash buffer (1% donkey serum, 0.1% triton, 0.3M NaCl) and incubated in 
secondary antibodies (Life Technologies, 1:500) at room temperature for two hours. Sections were 
then incubated in Hoechst (ThermoFisher, 1:10K) for 1 minute and washed 7 times for 15 minutes 
in wash buffer, mounted and coverslipped. 
2.2.6  Image acquisition and quantification 
Full-tissue thickness sections were imaged using either an Olympus BX53 fluorescent 
microscope with UPlanSApo 4X, 10X, or 20X objectives or a Nikon A1R confocal microscope 
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with 20X or 60X objectives. All images were quantified and analyzed using ImageJ. For all 
images, background pixel intensity was subtracted as calculated from control mice. To quantify 
the area of synapses observed, confocal images using single optical planes were converted into a 
binary scale and area of signal taken as a ratio of the total area (one section per region of interest, 
n = 6 mice). To quantify the number of Gad2Cre neurons labeled, a single optical plane was 
imagined from full-tissue thickness sections and neurons were manually quantified. To quantify 
CTB-labeled cells in tracing experiments, confocal images were manually quantified in a 
stereological manner using full-tissue thickness z-stacked images at 2 μm steps of the entire lPBN 
(3 – 4 mice per group). 
2.2.7  Behavior 
All assays were performed and scored by an experimenter blind to virus (eYFP or ChR2). 
Post hoc analysis confirming specificity of viral injections and proper fiber implantation were also 
performed blinded to animal identity, and mice in which viral injections and/or fiber implantation 
were considered off target excluded from analysis. All testing was performed in the University of 
Pittsburgh Rodent Behavior Analysis Core. The following optogenetic stimulation parameters 
were used: 10 mW, 20 Hz, 5 ms duration pulses.  
Mechanical allodynia  
Mice were allowed to habituate for at least two hours prior to testing. Mice received a 10 
ul intraplantar injection of 0.03% capsaicin dissolved in 2.5% Tween, 2.5% ethanol in PBS and 
tested for mechanical hypersensitivity via the up-down method (Chaplan et al., 1994). After 5-10 
minute resting period, mice were optogenetically stimulated and tested for mechanical 
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hypersensitivity. Mice were again allowed to rest for 5-10 minutes before von Frey testing for 
post-stimulation effects on mechanical hypersensitivity.  
2.2.8  Statistical analysis 
All statistical analyses were performed using GraphPad Prism 7.0. Values are presented as 
mean ± SEM. Statistical significance was assessed using one-way repeated measures ANOVA 
followed by Holm-Sidak post-hoc test or two-way repeated measures ANOVA followed by Holm-
Sidak post-hoc test. Significance was indicated by p ≤ 0.05. Sample sizes were based on pilot data 
and are similar to those typically used in the field.  
2.3 Results 
2.3.1  Inhibition of lPBN on the nociceptive response and lPBN connectivity 
Nociceptive information is conveyed from the spinal cord to multiple regions of the brain 
in parallel, including brainstem, midbrain and forebrain structures (Todd, 2010). Within the lPBN, 
neurons throughout all cytoarchitecturally distinct divisions respond quite robustly to different 
forms of noxious stimuli, as suggested by the expression of the early immediate gene Fos (Bernard 
et al., 1994; Bester et al., 1997; Bourgeais et al., 2001; Hermanson and Blomqvist, 1996, 1997; 
Menendez et al., 1996). Although the lPBN is a major target of the anterolateral tract in murine 
species (Todd, 2010; Todd et al., 2000), its relative contribution to pain behaviors has only recently 
been explored (Alhadeff et al., 2018; Barik et al., 2018; Huang et al., 2018; Rodriguez et al., 2017). 
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Moreover, these neurons are thought to be excitatory, thus conveying the nociceptive input from 
spinal cord to downstream forebrain targets that drive appropriate behavioral and autonomic 
responses to these noxious signals. To further understand the contributions of lPBN to pain 
behaviors, we tested whether transiently inhibiting the lPBN would affect the behavioral response 
to noxious stimuli. For these experiments, adenoassociated virus (AAV) encoding a Cre-dependent 
channelrhodopsin-2 (ChR2) or enhanced yellow fluorescent protein (eYFP) was bilaterally 
delivered into the lPBN using the Gad2Cre allele. This allows us to optogenetically control the 
activity of inhibitory neurons within the lPBN in live, behaving mice. (Figures 1A and 1B). In the 
absence of blue light, both ChR2 and eYFP mice showed capsaicin-induced mechanical 
hypersensitivity.  
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Figure 2 Distribution of inhibitory lPBN neurons 
(A) Visualization of Gad2Cre neurons in lPBN. Scale bar = 100 μm. 
(B) Quantification of the number of Gad2Cre neurons in dPBN vs. elPBN. (n = 5 mice).  
(C) Representative image of FISH between Vglut2 and Gad2 (Top) or Vgat and Gad2 (Bottom). Scale bar = 50 μm 
(D) Quantification of colocalization between Vglut2 and Gad2 or Vgat and Gad2. n = 4 mice.  
 
(A) Experimental strategy to drive inhibition in the lPBN. AAVs encoding Cre-dependent ChR2 or eYFP were 
bilaterally injected into the lPBN of Gad2Cre
 
mice. Representative image depicts expression of ChR2 within the 
lPBN (outline). Scale bar = 100 m.  
(B) Mechanical hypersensitivity was (1) induced through intraplantar injection of capsaicin (10 l, 0.03%) and (2) 
tested using von Frey filaments.  
(C) Paw withdrawal threshold (PWT) was significantly reduced during optogenetic stimulation (blue bar) in 
ChR2-expressing mice compared to eYFP-expressing controls. Data are mean ± SEM (n = 10 – 11 mice per group) 
** indicates significantly different (two-way RM ANOVA followed by Holm-Sidak post-hoc test: p = 0.008).  
Figure 1 lPBN is required for mechanical hypersensitivity 
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However, this hypersensitivity was significantly reduced when the lPBN was photostimulated in 
ChR2 mice compared to eYFP controls (Figure 1C). These data indicate that optogenetic 
activation of Gad2 – expressing neurons in lPBN is sufficient to reduce mechanical 
hypersensitivity, suggesting that activity within the lPBN is required for mechanical allodynia.  
Next, we used immunohistochemistry to determine the location and number of inhibitory 
neurons targeted through our viral strategy (Figure 2A – 2B). We found comparable numbers of 
inhibitory neurons expressing eYFP in dPBN compared to elPBN (123.1 ± 14.7 vs. 74.9 ± 5.4 
neurons, respectively; paired Student’s t test, p = 0.063). Furthermore, the number of neurons per 
unit area was not different (1856.4 ± 222.1 vs. 1791.9 ± 129.8 neurons per mm2, respectively). To 
verify that these Gad2 – expressing neurons indeed are inhibitory, we performed fluorescent in 
situ hybridization to visualize the colocalization of Gad2 with either Vglut2 or Vgat (Figure 2C). 
Roughly 3% of Gad2-positive neurons colocalized with Vglut2, whereas approximately 90% of 
Gad2-positive neurons colocalized with Vgat (Figure 2D). These data argue that the lPBN 
population expressing Gad2 that we targeted indeed are inhibitory. Together, these data suggest 
that the Gad2Cre labels inhibitory neurons, and our optogenetic activation of the Gad2Cre lPBN 
neurons equally targeted both dPBN and elPBN inhibitory subpopulations.  
Given the necessity of the lPBN for this pain behavior, we next explored its efferent targets. 
Towards this end, an AAV encoding a Cre-GFP fusion protein was stereotaxically delivered into 
the lPBN of transgenic mice harboring two Cre-dependent alleles: ReaChR-mCitrine, for the 
purpose of visualizing axonal projections, and synaptophysin-tdTomato, for the purpose of 
visualizing presynaptic terminals (Figure 3A). We observed lPBN efferent projections to 
numerous regions of the brain (Figure 5), consistent with previous studies (Bernard et al., 1996; 
Bernard et al., 1994; Gauriau and Bernard, 2002a; Saper and Loewy, 1980). However, four targets 
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in particular stood out due to the robust projections from mCitrine-labeled axons and dense puncta 
from tdtomato-labeled synaptic terminals: the BNST, the CEA, the VMH, and the lPAG (Figures 
3B and 3C). Quantification revealed that all four of these regions received significant synaptic 
input from the lPBN (Figure 3D), though the apparent perisomatic input to the BNST and CEA 
(arrows) was qualitatively different from the diffuse input observed within the VMH and lPAG  
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Figure 3 lPBN projects to four major targets. 
(A) Experimental design and representative image of strategy to visualize lPBN neurons, their projections, and their 
presynaptic terminals. An AAV encoding a Cre-GFP fusion protein was targeted to the lPBN into mice harboring 
two Cre-dependent alleles, R26
LSL-ReaChR-mCitrine 
and R26
LSL-Syn-tdt
. Scale bar = 100 m.  
(B) Projections of the lPBN efferents to four different brain regions, as visualized with ReaChR- mCitrine: BSNT, 
CEA, VMH and lPAG. Scale bar = 100 m. Images are representative of results from 6 mice. 
(C) Synaptic terminals of lPBN efferents at four indicated targets, as visualized with Synaptophysin-tdtomato. Scale 
bar = 25 m. Arrowheads and arrows denote perisomatic and diffuse input, respectively.  
(D) Quantification of synaptic input. The relative synaptic input from lPBN was estimated by quantifying the area 
of synaptophysin-tdtomato expression within the indicated target. Motor cortex, which exhibits no synaptophysin-
tdtomato expression, was used as negative control. Data are mean ± SEM and dots represent data points from 
individual animals (n = 6 mice). Asterisks indicate significantly different than negative control region (one-way RM 
ANOVA followed by Holm-Sidak post-hoc test; ** p < 0.01, **** p < 0.001).  
(E) Summary diagram depicting four major efferent targets of lPBN.  
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(arrowheads; Figure 3C). Together, these data indicate that the BNST, CEA, VMH, and lPAG are 
four principle efferent targets of the lPBN (Figure 3E). 
The observation that lPBN targets four principle downstream targets led us to wonder 
whether the reduction in mechanical allodynia during optogenetic stimulation of inhibitory lPBN 
neurons could be mediated through mechanisms downstream of lPBN. We therefore visualized the 
projections of Gad2Cre lPBN neurons through stereotaxic injections of cre-dependent AAV 
encoding ChR2-eYFP (Figure 5). We found axon terminals from Gad2Cre neurons primarily in 
BNST, CEA, VMH, and lPAG (Figure 4A). However, the relative projection intensity was less 
than that when the total lPBN population as targeted (Figure 4B). This argues that the majority of 
lPBN outputs are excitatory. 
 
(A) Gad2-cre neurons in lPBN project to BNST, CEA, VMH, and lPAG.  
(B) Quantification of projection intensity from all lPBN or Gad2Cre neurons to BNST, CEA, VMH, and lPAG. (n = 
5 mice, two-way RM ANOVA followed by Holm-Sidak post-hoc test; * p < 0.05; ** p < 0.01; *** p < 0.001; 
**** p < 0.0001). 
Figure 4 Inhibitory lPBN projections to four major targets. 
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Figure 5 Efferents from the lPBN target numerous brain regions. 
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2.3.2  Anatomical characterizations of collateral output pathways from the lPBN 
Next, we sought to investigate the cellular basis of these efferent projections in more detail. 
In particular, we considered whether there might be parallel pathways originating from distinct 
cell types within the lPBN (Figure 6A), which would be consistent with previous work suggesting 
that distinct subdivisions of the LBPN have distinct projection patterns (Fulwiler and Saper, 1984; 
Saper and Loewy, 1980). Alternatively, given that at least some lPBN efferents are known to 
collateralize (Tokita et al., 2010), we also considered the possibility of a single major output from 
the lPBN with multiple targets (Figure 6B). To distinguish between these possibilities, we 
characterized the projections from the lPBN using cholera toxin B subunit (CTB) as a retrograde 
tracing tool (Figure 6C). Intriguingly, we found that stereotaxic injection of CTB into distinct 
Efferents from the lPBN targets numerous brain regions, as visualized following stereotaxic injection of an AAV 
encoding eYFP into the lPBN (0.2 l, bilateral). 
(A) Graphical illustration of viral delivery approach to target all lPBN neurons (top) or an inhibitory subset 
expressing Gad2Cre (bottom). 
(B) Medial ventral division of bed nucleus stria terminalis (BNSTMV). 
(C) Median preoptic nucleus (MnPO). 
(D) Anteroventral periventricular nucleus (AVPV). 
(E) Insular cortex. 
(F) Basomedial amygdaloid nucleus (BMA). 
(G) Paraventricular thalamic nucleus (PV). 
(H) Centromedial thalamic nucleus (CM) and rhomboid nucleus (RH). 
(I) Lateral hypothalamus (LH). 
(J) Lateral reticular nucleus (LRN). 
(K) Rostral ventromedial medulla (RVM). Scale bar = 200 m (B - K)  
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lPBN targets labeled neuronal cell bodies in different sub-regions of the lPBN: retrograde tracing 
from BNST or CEA resulted in labeled neurons within the elPBN, whereas retrograde tracing from 
VMH or lPAG labeled neurons within the dPBN (Figure 6D). These findings suggested the 
existence of at least two populations of efferent neurons with distinct targets.  
To further explore this idea, we performed dual retrograde labeling experiments, placing 
distinct CTB conjugates into different target regions through stereotaxic injections. Following dual 
targeting of CEA and BNST, we found that ~40% of labeled neurons in the lPBN were double-
labeled with both CTB-conjugated fluorophores (Figure 6E). Analogously, following dual 
injection into the VMH and lPAG, ~30% of CTB-containing neurons in the lPBN were double-
labeled (Figure 6F). In contrast, there was almost no double labeling of lPBN neurons upon dual 
injections into any of the other four pair-wise combinations (Figures 6G, 6H, 6I and 6J). Together, 
these data define two major efferent pathways from the lPBN that exhibit collaterals: one 
originating from the dPBN that collateralizes to the VMH and lPAG, and a second arising from 
the elPBN that collateralizes to the BNST and CEA (Figure 6K). 
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Figure 6 Distinct subpopulations of lPBN collateralize to different forebrain regions 
(A-B) Models illustrating lPBN efferents as parallel (A) or divergent pathways (B). 
(C) Experimental strategy to retrogradely label lPBN efferents with fluorophore-congugated CTB. 
(D) CTB injections into efferent targets (top) and retrogradely labeled cells (bottom) in elPBN (BSNT and CEA) 
and dPBN (VMH and lPAG). Scale bars = 100 m. 
(E) Dual injection of CTB into CEA (green) and BNST (red) resulted in colocalized signal in approximately 40% 
of retrogradely labeled cells (yellow) across entire lPBN. Data are mean ± SEM (n = 4 mice). Arrows highlight co-
labeled cells. Scale bar = 50 m. Magnification shown in inset. Scale bar = 10 m. 
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2.4 Discussion 
In this chapter we provided evidence demonstrating two distinct pathways emanating from 
the lPBN. We identified robust terminal endings in four downstream regions that we characterized 
as major efferent pathways. Retrograde labeling from these regions identified spatially distinct 
lPBN subpopulations that collateralize to these downstream targets. Those from the dPBN 
collateralize to the VMH and lPAG, whereas a separate subpopulation from elPBN collateralize 
to BNST and CEA. These anatomical tracing studies suggest that divergent pathways from lPBN 
may underlie functionally distinct pathways that govern different aspects of behavior. 
Furthermore, we used genetically engineered mice expressing Cre recombinase in a subset of 
inhibitory lPBN neurons under the Gad2 promoter, thereby allowing us to virally target and 
optogenetically activate this population to determine their functional contributions in a test of acute 
pain. This experiment revealed transient and reversible reduction in mechanical hypersensitivity 
through the activation of Gad2-expressing inhibitory neurons.  
A novel finding through our experiment was the ability to reduce mechanical 
hypersensitivity through the activation of an inhibitory lPBN population. Prior work on lPBN 
(F) Dual injections of CTB into VMH (blue) and lPAG (purple) resulted in colocalized signal in 30% of retrogradely 
labeled cells (white) across entire lPBN. Data are mean ± SEM (n = 4 mice). Arrows highlight co-labeled cells. 
Scale bar = 50 m. Magnification shown in inset. Scale bar = 10 m. (G-J) Very few dual-labeled neurons were 
observed following dual CTB injections into: CEA and VMH (G); CEA and lPAG (H); BNST and VMH (I); or 
BNST and lPAG (J). Data are mean ± SEM (n = 3 - 4 mice). Scale bar = 50 m. 
(K) Summary diagram illustrating two collateral pathways emerging from lPBN.  
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circuitry and function have previously described predominantly excitatory populations within 
lPBN that respond to nociceptive stimuli (Guthmann et al., 1998; Yokota et al., 2007). 
Furthermore, these excitatory populations, some of which project to downstream forebrain regions, 
serve integral roles in mediating different aspects of nociceptive behavior (Barik et al., 2018; Chen 
et al., 2018). As the inhibitory populations within downstream targets, such as the BNST and CEA, 
have been well-described (Babaev et al., 2018; Fadok et al., 2017; Gungor and Pare, 2016; Li et 
al., 2013), the modulation of these excitatory lPBN outputs have been either implicated to occur 
at these downstream regions or arise from inhibitory inputs onto lPBN excitatory neurons, thus 
painting an unappreciated role of inhibitory lPBN subsets in modulating lPBN activity. It is 
important to make clear that the lPBN exhibits dense GABA-immunoreactive varicosities, 
indicating that the lPBN is under strong GABAergic inhibition capable of suppressing lPBN 
activity (Coizet et al., 2010; Guthmann et al., 1998). However, whether this inhibitory regulation 
arises from local interneurons remains to be determined. Characterizing the morphology of 
Gad2Cre lPBN neurons would provide insight into the ability of these neurons to broadly inhibit 
lPBN activity and subsequent pain behavior as these neurons are broadly distributed throughout 
lPBN. 
Interestingly, we found that not all Gad2-expressing population were local interneurons as 
indicated by the presence of projections to a few downstream forebrain targets. In contrast, 
anatomical tracing data from the Allen Brain Institute indicate much sparser to no projections to 
these regions (Experiment: 303535149, http://connectivity.brain-map.org/). This is not entirely 
inconsistent with our findings, as the difference is likely a result of the greater number of inhibitory 
neurons within lPBN that were targeted in our experiment compared to those performed at the 
Allen Brain Institute. This leaves open the possibility of whether the observed increase in paw 
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withdrawal threshold was mediated through the optogenetic activation of local Gad2-positive 
neurons or Gad2 – expressing projection neurons. However, the relative proportion of inhibitory 
projections to forebrain targets are small compared to those of the excitatory population, 
suggesting that the reduction in mechanical allodynia when photoactivating the lPBN inhibitory 
population likely arises from the activity of local inhibitory interneurons within lPBN. Lastly, our 
viral delivery and optical fiber implantations were localized to the PBN complex, further 
supporting our interpretation that the reduction in mechanical hypersensitivity resulted from lPBN 
Gad2Cre interneuron activity and not inhibitory neurons from adjacent brain structures.  
An additional novel finding from these experiments is the collateralization of distinct lPBN 
subpopulations. We described results in which two distinct subdivisions of lPBN collateralize to 
separate targets. Roughly 30% of backlabeled dPBN neurons collateralize to both VMH and lPAG, 
whereas 40% of backlabeled elPBN neurons collateralizes to BNST and CEA. Although previous 
anatomical characterizations of lPBN efferents have demonstrated that these projections arise from 
distinct subdivisions of lPBN, few have characterized the collateralization of these efferent 
pathways and, to our knowledge, the degree of colocalization among these lPBN projection 
neurons has not been reported (Sarhan et al., 2005). Liang et al. 2016 retrogradely labeled from 
CEA and PVT and found less than 10% of cells colocalized compared to the 40% colocalization 
of BNST- and CEA-projecting lPBN neurons in our experiments (Liang et al., 2016a). It is 
important to raise the technical concern that these retrograde tracing approaches do not definitively 
label all lPBN projection neurons. Thus, it is possible that the 30% dPBN- and 40% elPBN- labeled 
neurons may be an underestimate of the total number of collateralizing neurons. Nevertheless, 
these data suggest that the lPBN population collateralizing between BNST and CEA, and those 
between VMH and lPAG, may indeed be major, unique subsets of lPBN neurons that convey 
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interoceptive or exteroceptive input from the periphery to forebrain structures. Although the 
availability of different retrograde tools has limited the number of collateralizations we could 
characterize in our experiments, we imagine that lPBN subsets may exhibit more than two 
collateral emergent pathways.  
An important detail not addressed in our tracing studies is the neurochemical composition 
of collateralizing pathways. Although the cytoarchitectural territories and divisions of lPBN have 
been carefully and thoroughly detailed (Fulwiler and Saper, 1984; Saper and Loewy, 1980), these 
subregions have yet to be categorized into genetically distinct cell types. The generation of 
genetically engineered mice harboring the Cre recombinase allele has permitted local, targeted 
delivery of transgenes into specific subsets of neurons within a heterogeneous population. Within 
the lPBN, the most notable is the CalcaCre allele in which Cre recombinase has been targeted to 
the Calca locus encoding CGRP (Carter et al., 2013; Rosenfeld et al., 1983). Tracing studies have 
demonstrated that CGRP-positive neurons reside almost exclusively within the elPBN and project 
to several forebrain targets including BNST and CEA (Chen et al., 2018). In a separate study, 
nearly all CEA- and PVT- projecting lPBN neurons expressed CGRP (Liang et al., 2016b). Thus, 
it is very likely that the elPBN neurons collateralizing to BNST and CEA we characterized also 
overlap to a significant degree with CGRP. On the other hand, the neurochemical identity of dPBN 
subpopulations has not been as thoroughly characterized. In Chapter 4, we identified a subset of 
dynorphin-expressing neurons in dPBN using PdynCre mice. However, they are unlikely to 
represent the subpopulation of neurons collateralizing to VMH and lPAG because anatomical 
tracing revealed no projections to VMH (data not shown). Further studies are warranted to 
determine the various cell types within each subdomain of the lPBN. 
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3.0 Activity of divergent lateral parabrachial pathways compose the nocifensive response 
3.1 Introduction 
Our work and previous studies have demonstrated segregated subpopulations within lPBN 
that give rise to different projection patterns, suggesting such outputs regulate different aspects of 
behavior in response to interoceptive and exteroceptive signals (Fulwiler and Saper, 1984; Liang 
et al., 2016b; Saper and Loewy, 1980; Tokita et al., 2010). Although there is general agreement 
that lPBN likely serves as a homeostatic alarm to notify an animal of potential danger from a 
diverse range of stimuli (Palmiter, 2018; Saper, 2016), the functional role of specific efferent 
pathways to downstream targets remains to be fully explored. The CGRP-expressing population 
in the elPBN, which has been the most well-described, projects to numerous downstream regions 
that, through redundant pathways, encode conditioned aversion to unpleasant or threatening 
stimuli (Chen et al., 2018; Han et al., 2015a). A partially overlapping population expressing the 
neuropeptide Tac1 exhibits similar projection patterns. However, its connections with the RVM 
trigger nocifensive behavior in response to noxious heat (Barik et al., 2018). The functional 
contributions to pain responses of the remainder of projections to numerous forebrain regions have 
yet to be characterized. In this chapter, we designed experiments to activate specific projections 
from elPBN and evaluate their effects on behavior in vivo.  
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3.2 Methods 
3.2.1  Animals 
Mice were given free access to food and water and housed under standard laboratory 
conditions. The use of animals was approved by the Institutional Animal Care and Use Committee 
of the University of Pittsburgh. Wild-type C57BL/6 mice were obtained from Charles River (Cat 
# 027). For all experiments 8 – 16 week-old male and female mice were used. In all cases, no 
differences between male and female mice were observed and so the data were pooled. 
3.2.2  Viruses 
The following viruses were used for experimentation: AAV2-hsyn-eYFP (Addgene: 
50465) and AAV2-hSyn-hChR2(H134R)-eYFP (Addgene: 26973). Viruses were purchased from 
University of North Carolina Vector Core.  
3.2.3  Stereotaxic injections and optical fiber implantation 
Stereotaxic injections and optical fiber implantations were performed as described in the 
previous chapter. Wildtype mice were bilaterally injected with 0.2 l virus. The injection needle 
was left in place for an additional 5- 10 min and then slowly withdrawn. Injections and optical 
fiber implantations were performed bilaterally at the following coordinates for each brain region: 
BNST: AP +0.50 mm, ML ± 1.00 mm, DV -4.30; CEA: AP -1.20 mm, ML ± 2.85 mm, DV -4.50; 
VMH: AP -1.48 mm ML ± -0.50 mm DV -5.80 mm; lPAG: AP -4.70 mm, ML ± 0.74 mm, DV: -
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2.75; and lPBN AP -5.11 mm, ML ± 1.25 mm, DV: -3.25. For implantation of optical fibers (Thor 
Labs: 1.25 mm ceramic ferrule 230 m diameter), implants were slowly lowered 0.300-0.500 mm 
above the site of injection and secured to the skull with a thin layer of Vetbond (3M) and dental 
cement. The incision was closed using Vetbond and animals were given a subcutaneous injection 
of buprenorphine (0.3mg/kg) and allowed to recover over a heating pad. Mice were given 4 weeks 
to recover prior to experimentation. 
3.2.4  Immunohistochemistry 
Immunohistochemistry was performed as described in the previous chapter. Primary 
antisera were incubated for 14 hours overnight at 4°C: chicken anti-GFP (1:1K) and rabbit anti-
Fos (1:5K). Sections were subsequently washed three times for 20 minutes in wash buffer (1% 
donkey serum, 0.1% triton, 0.3M NaCl) and incubated in secondary antibodies (Life Technologies, 
1:500) at room temperature for two hours. Sections were then incubated in Hoechst 
(ThermoFisher, 1:10K) for 1 minute and washed 7 times for 15 minutes in wash buffer, mounted 
and coverslipped. 
3.2.5  Image acquisition and quantification 
Full-tissue thickness sections were imaged using either an Olympus BX53 fluorescent 
microscope with UPlanSApo 4X, 10X, or 20X objectives or a Nikon A1R confocal microscope 
with 20X or 60X objectives. All images were quantified and analyzed using ImageJ. For all 
images, background pixel intensity was subtracted as calculated from control mice. To quantify 
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Fos-labeled cells, 65 m sections of the entire lPBN were imaged using the fluorescent microscope 
and images manually counted in a blinded manner.  
3.2.6  Fos induction (optogenetics) 
To induce Fos in optically implanted mice, mice were photostimulated at 10 mW, 20 Hz, 
and 5 ms pulse duration for 20 minutes at a 3 seconds on, 2 seconds off stimulation pattern and 
subsequently perfused 90 minutes after the initial onset of photostimulation as noted for 
immunohistochemistry. 65 um thick transverse sections of brain were collected on a vibratome 
and processed free-floating for immunohistochemistry as detailed above. To quantify Fos-labeled 
cells, we identified the center of each full-thickness tissue section and imaged 3 optical planes that 
were 10 m apart. These images were subsequently merged into a single layer and counted for 
each region of interest (lPBN, BNST, CEA, VMH, and lPAG).  
3.2.7  Behavior 
All assays were performed and scored by an experimenter blind to virus (eYFP or ChR2). 
Post hoc analysis confirming specificity of viral injections and proper fiber implantation were also 
performed blinded to animal identity, and mice in which viral injections and/or fiber implantation 
were considered off target excluded from analysis. All testing was performed in the University of 
Pittsburgh Rodent Behavior Analysis Core. Optogenetic stimulation parameters were determined 
empirically as follows: 10 mW, 20 Hz, 5 ms duration pulses.  
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Real time place aversion assay (RTPA)  
Mice were stereotaxically injected with either channelrhodopsin or control eYFP virus and 
optical fibers implanted at the downstream terminals of interest. Four weeks following injection 
mice were habituated to a custom-made 2-chamber (40cm x 28cm x 20cm chamber) for real time 
place aversion testing. Mice were habituated on day 1 for 20 minutes and subsequently tested the 
next day for 20 minutes. Light stimulation was delivered whenever the mouse entered one of two 
sides of the chamber and turned off when the animal exited that chamber. The side of stimulation 
was counterbalanced. The behavior was recorded and post-hoc analysis performed to determine 
body position using the open source software Optimouse (Ben-Shaul, 2017). Position data were 
discarded according to established criteria, and velocity was computed as described here 
(https://www.biorxiv.org/content/10.1101/558643v1).  
Tail immersion test  
Mice were habituated to mouse restraints 15 minutes for 5 days before testing. Tails were 
immersed 3 cm into a water bath at 48°C or 55°C, and the latency to tail flick was measured three 
times per temperature with a 1 minute interval between trials. For optogenetic testing, mice were 
photostimulated for 10 seconds prior to tail immersion testing.  
Escape response test  
Mice were placed in an open field chamber and allowed to habituate for five minutes before 
two 30-second optogenetic stimulation bouts and two minute resting period between bouts. The 
behavior was recorded and post-hoc analysis performed to determine body position using the open 
source software Optimouse as described in RTPA.  
Conditioned place aversion test  
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Mice were placed in a two-chamber plexiglass box for 20 minutes and allowed to freely 
roam between one of two sides differentiated by visual cues (spots versus stripes). For two 
conditioning days, mice were restricted to one of two sides and received either no stimulation or 
photostimulation (3 seconds on, 2 seconds off at 20Hz, 5ms pulse duration, 10mW) for 20 minute 
periods in the morning and afternoon. On the test day, mice were placed back into the box and 
allowed to freely explore either chamber. The behavior was recorded and post-hoc analysis 
performed to determine body position using the open source software Optimouse as described in 
RTPA. For formalin-induced CPA, mice were conditioned to 2% 10μl solution of formalin injected 
into either one hindpaw on the first day of conditioning and the contralateral hindpaw on the second 
day of conditioning. Control mice received no hindpaw injections. 
3.2.8  Statistical analysis 
All statistical analyses were performed using GraphPad Prism 7.0. Values are presented as 
mean ± SEM. Statistical significance was assessed using Fisher’s exact test for categorical data, 
Students t-test, or two-way repeated measures ANOVA followed by Holm-Sidak post-hoc test. 
Significance was indicated by p ≤ 0.05. Sample sizes were based on pilot data and are similar to 
those typically used in the field.  
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3.3 Results 
3.3.1  dPBN projections and nociceptive behavior 
Our two main findings from the previous chapter, that 1) the activity of inhibitory lPBN 
neurons can reduce mechanical allodynia and 2) distinct subdivisions of the lPBN collateralize to 
different targets, led us to ask whether distinct outputs from the lPBN underlie different 
components of the nocifensive response. To address this question, we targeted the lPBN with 
AAVs encoding either ChR2 or eYFP and implanted optical fibers above distinct efferent targets, 
thereby enabling pathway-selective stimulation (Figure 7A). For each mouse, behavioral 
experiments and post-hoc analysis of tissue for infection specificity in the lPBN and optical 
placement over the efferent target were performed in a blinded manner.  
Several lines of evidence suggest that nociceptive threshold is determined, at least in part, 
by descending modulation from brain structures such as the PAG that are activated by ascending 
nociceptive circuitry (Basbaum and Fields, 1978). To explore whether any of the efferent 
projections from the lPBN are sufficient to activate descending inhibition, we assessed whether 
optogenetic stimulation affected the latency to withdraw in the tail flick assay, which measures a 
spinal reflex to noxious heat (Figure 7B). At baseline, ChR2-expressing mice exhibited similar tail 
flick latencies compared to eYFP controls. However, immediately following optogenetic 
activation of dPBN projections to lPAG, ChR2-expressing mice showed a significant increase in 
tail flick latency (Figure 7C). Indeed, over half of these mice reached cut-off, which was imposed 
to prevent tissue damage. In contrast, photostimulation of projections to other efferent targets had 
either no significant effect (VMH or CEA) or only a small effect (BNST) (Figures 8A, 8B and 
 43 
8C). Thus, activation of the efferent pathway from the lPBN to the lPAG is sufficient to elicit 
robust analgesia that likely activating descending inhibition. 
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Figure 7 Efferent dPBN projections to VMH and lPAG elicit escape-like behaviors 
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(A) Experimental strategy to selectively activate distinct lPBN projections. AAVs encoding either ChR2 or eYFP 
were injected into the lPBN and optical implants were placed above one of four efferent targets: lPAG, VMH, 
CEA or BNST. 
(B) Experimental protocol for tail flick assay (TFA). Mice were photostimulated for 10 s immediately prior to 
TFA at either 48 C and 55 C. 
(C) Photostimulation of dPBN terminals in lPAG significantly increases latency to tail flick at 48 C and 55 C. 
Data are mean ± SEM and dots represent data points from individual animals (n = 9 – 11 mice per group). **** 
indicates significantly different (Two-way RM ANOVA followed by Holm-Sidak post-hoc test; lPAG, p < 
0.0001). Dotted lines indicate cut-off latencies that were imposed to prevent tissue damage. 
(D) Experimental protocol for running assay. Stimulation paradigm and example traces of locomotion following 
stimulation of lPAG terminals from lPBN efferents in eYFP and ChR2 mice. 
(E) Photostimulation of dPBN terminals in lPAG significantly increases locomotion. Data are mean ± SEM (n = 
9 – 11 mice per group). **** indicates significantly different (Two-way ANOVA followed by Holm-Sidak post-
hoc test, p < 0.0001)  
(F) Photostimulation of dPBN terminals in VMH significantly increases locomotion. Data are mean ± SEM (n = 
10 – 12 mice per group). **** indicates significantly different (Two-way ANOVA followed by Holm-Sidak post-
hoc test, p < 0.0001). 
(G) Experimental protocol for jumping assay. A minimum of 6 cm vertical movement of the body was considered 
a jump.  
(H) Photostimulation of dPBN terminals in lPAG elicits significant jumping. Data are mean ± SEM and dots 
represent data points from individual animals (n = 9 – 11 mice per group). Left: * indicates significant number of 
jumps (Mann-Whitney; p = 0.033). Right: * indicates significant proportion of mice (Fisher’s exact test: p = 0.033).  
(I) Photostimulation of dPBN terminals in VMH elicits significant jumping. Data are mean ± SEM and dots 
represent data points from individual animals (n = 9 – 11 mice per group). Left: * indicates significant number of 
jumps (Mann-Whitney; p = 0.015). Right: * indicates significant proportion of mice (Fisher’s exact test: p = 0.015). 
(J) Summary diagram depicting behavioral responses observed upon stimulation of dPBN efferents to VMH and 
lPAG.  
 46 
 
Figure 8 Effect of photoactivation of lPBN on descending modulation, running, and jumping. 
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Over the course of these studies, we noted that activation of some efferent pathways elicited 
motor behaviors. To examine this phenomenon in more detail, we quantified the lateral (Figure 
7D; running) and vertical (Figure 7G; jumping) movements that were observed upon optogenetic 
stimulation. Activation of the efferent projection from the dPBN to the lPAG resulted in explosive 
running behavior that was time-locked to the light stimulus (Figure 7E). Likewise, stimulation of 
the projection to the VMH elicited dramatic increased in locomotion that began each time the light 
was turned on and ceased as soon as the light was turned off (Figure 7F). In contrast, 
photostimulation of efferent projections to the CEA caused no significant lateral movement 
(A-B) Optogenetic activation of terminals in VMH or CEA of ChR2-injected mice (blue bars) does not 
increase latency of tail flick response to low or high noxious heat compared to eYFP-expressing controls 
(grey). Data are mean ± SEM and dots represent data points from individual animals (n = 8 - 9 mice per 
group; ns, not significant p > 0.05, two-way RM ANOVA). 
(C) Photostimulation of projections to BNST in ChR2-expressing mice (blue bars) increases latency to tail 
flick at 48 C but not 55 C compared to control mice (grey bars). Data are mean ± SEM and dots represent 
data points from individual animals (n = 10 - 11 mice per group; * indicates significant, two-way RM 
ANOVA followed by Holm-Sidak post-hoc test, p = 0.03).  
(D) Optogenetic stimulation of terminals in CEA of ChR2-injected mice has no effect on lateral movement. 
Data are mean ± SEM (n = 8 – 9 mice per group; ns, not significant, two-way RM ANOVA, p > 0.05). 
(E) Optogenetic stimulation of terminals in BNST promotes significant lateral movement in the first but 
not second bout of photostimulation. Data are mean ± SEM (n = 10 - 11 mice per group, **** indicates 
significant difference, two-way RM ANOVA followed by Holm-Sidak post-hoc test, p < 0.0001).  
(F - G) The number of jumps or proportion of mice exhibiting jumping was not significantly higher in 
ChR2-expressing mice that were stimulated in CEA or BNST compared to eYFP controls (Mann-Whitney 
t-test: CEA: p = 0.47; BNST: p = 0.21, Fisher’s exact test: CEA: p = 0.47; BNST: p = 0.21). Data are mean 
± SEM and dots represent data points from individual animals (n = 9 - 11 mice per group).  
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(Figure 8D), and that to the BNST showed significant lateral movement to the first stimulation 
only (Figure 8E). Thus, efferent projections from the dPBN were distinctive in their ability to elicit 
switch-like locomotor behavior in response to repeated stimulation. 
Analogous results were found in the jumping assay, where significant effects were 
observed upon activation of efferents originating from the dPBN, but not the elPBN. Upon 
activation of projections to either the lPAG or the VMH, a significant proportion of mice (50%) 
jumped as many as 35 times over a minute of stimulation (Figures 7H and 7I). In contrast, jumping 
behavior upon activation of the efferent pathways to either the BNST or the CEA was not 
significantly different than that observed in eYFP controls (Figures 8F and 8G). Taken together, 
these finding suggest that the efferent pathways emanating from the dPBN are sufficient to elicit 
a group of behaviors — running, jumping and analgesia — that would enable escape in the context 
of injury or other threats (Figure 7I). 
Optogenetic activation of terminal fields provides a method to study pathway-specific 
behaviors. However, a caveat of this technique is the possibility of back-propagation of action 
potentials that may result in antidromic activation of projections to other downstream targets. To 
confirm the specificity of circuit activation, thereby allowing us to correlate the observed behaviors 
to a specific lPBN projection, we analyzed the induction of Fos, a marker of neuronal activity, in 
response to optogenetic stimulation (Figure 9).  
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Figure 9 Pathway selective photostimulation of lPBN outputs 
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To assess the degree to which photstimulation of a specific lPBN efferent was selective, Fos induction was 
analyzed 90 min after photostimulation (20 min; 20 Hz, 5 ms pulses, 10 mW). 
(A) Diagram and image of ChR2-expressing terminals and Fos-expressing cells in BNST. 
(B) Fos induction in eYFP-expressing mice (control, grey) and ChR2-expressing mice (blue) upon 
photostimulation of lPBN efferent terminals in the BNST. Data are mean ± SEM and dots represent data points 
from individual animals (n = 8 - 11 mice per group). 
(C) The number of Fos-expressing cells in BNST is significantly greater than that in CEA (paired Student’s t-
test p = 0.01, n = 11 mice).  
(D) Diagram and image of ChR2-expressing terminals and Fos-expressing cells in CEA.  
(E) Fos induction in eYFP- expressing mice (control, grey) and ChR2-expressing mice (blue) upon 
photostimulation of lPBN efferent terminals in the CEA. Data are mean ± SEM and dots represent data points 
from individual animals (n = 8 - 9 mice per group)  
(F) The number of Fos-expressing cells in CEA is significantly greater than that in BNST (paired Student’s t-
test p = 0.004, n = 9 mice).  
(G) Diagram and image of ChR2-expressing terminals and Fos-expressing cells in VMH. 
(H) Fos induction in eYFP- expressing mice (control, grey) and ChR2-expressing mice (blue) upon 
photostimulation of lPBN efferent terminals in the VMH. Data are mean ± SEM and dots represent data points 
from individual animals (n = 10 - 11 mice per group). 
(I) The number of Fos-expressing cells in VMH is significantly greater than that in lPAG (paired Student’s t-
test, p = 0.04, n = 10).  
(J) Diagram and image of ChR2-expressing terminals and Fos-expressing cells in VMH. 
(K) Fos induction in eYFP- expressing mice (control, grey) and ChR2-expressing mice (blue) upon 
photostimulation lPBN efferent terminals in the VMH. Data are mean ± SEM and dots represent data points 
from individual animals (n = 9 - 10 mice per group) 
(L) The number of Fos-expressing cells in lPAG is significantly greater than that in VMH (paired Student’s t-
test p = 0.004, n = 9). Scale bar = 100 m outer, 50 m inner (A, D, G, J). 
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3.3.2  elPBN projections on aversive learning 
Another important component of the response to noxious input is aversion that provides a 
salient cue to enable avoidance learning. We therefore addressed the degree to which efferent 
pathways from the lPBN elicit avoidance using a real-time place aversion assay (Figure 10A). As 
before, experiments were performed on mice in which AAVs encoding either ChR2 or eYFP had 
been stereotaxically injected into the lPBN and optical fibers were implanted above one of the four 
efferent targets — CEA, BNST, VMH or lPAG — to enable pathway-selective activation. Notably, 
regardless of which lPBN efferent pathways that was targeted, ChR2-expressing mice spent 
significantly less time on the side of the chamber in which they received photostimulation (Figures 
10B, 10C, 4D, 10E and 10F).  
Although this behavior was suggestive of aversion, we also considered the possibility that 
at least in some instances (i.e., VMH and lPAG) this apparent avoidance could simply be a 
consequence of optogenetically-induced locomotion. Thus, to more directly assess whether 
activation of efferent pathways from the lPBN was sufficient to enable associative conditioning, 
we used the conditioned place aversion (CPA) assay, in which optogenetic stimulation was 
selectively paired with one of the two chambers for 20 min on two consecutive days (Figure 10G).  
When activation of efferent projections to the CEA was the conditioning stimulus, ChR2-
expressing mice spent significantly less time on the stimulation-paired side of the chamber (Figure 
10H). Similarly, significant CPA was observed when activation of projections to the BNST was 
used as the conditioning stimulus (Figure 10I). In contrast, repeated photostimulation of efferent 
projections to either the VMH or the lPAG failed to induce CPA (Figures 11A and 11B). These 
findings suggest that, although activation of any of the the major outputs from the lPBN results 
(directly or indirectly) in real time place aversion (RTPA), only those projecting to the CEA or  
 52 
 
 
Figure 10 Efferent elPBN projections to BNST and CEA drive aversion. 
(A) Experimental protocol for real time place aversion (RTPA) assay. Mice were habituated (Hab) for 20 min 
one day prior to testing (Test). 
(B) Heat maps of time spent in RTPA chambers upon stimulation of lPBN terminals in CEA in eYFP (left) and 
ChR2 (right) mice. 
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BNST are sufficient for stable aversive learning. To further explore how quickly the mice learned 
to avoid the side of the chamber in which they receive optogenetic stimulation, we re-analyzed the 
real time place aversion data, quantifying number of entries into the light-paired chamber. 
Photostimulation of the efferent projection to the CEA significantly reduced the number of entries 
(Figure 10J), whereas activation of other efferent projections had no significant effect on entries 
(Figures 11C, 11D and 11E). These findings reinforce the role of projections to the CEA for 
avoidance learning because only this cohort of mice showed evidence of learning to avoid the 
light-paired chamber during the RTPA assay. Together, these data suggest that avoidance memory 
can be elicited by efferent pathways from the elPBN (Figure 10K), consistent with previous studies 
(Campos et al., 2018; Chen et al., 2018; Han et al., 2015a; Sato et al., 2015). 
(C-F) Time spent in photostimulation chamber during habituation phase (Hab) and testing phase (Test) in eYFP 
(grey) and ChR2 (blue) mice upon stimulation of lPBN efferent terminals in the CEA (C), BNST (D), VMH (E) or 
lPAG (F). Data are mean ± SEM and dots represent data points from individual animals (n = 9 – 11 mice per group 
for each experiment). **** Indicates ChR2 mice are significantly different than eYFP controls (Two-way RM 
ANOVA followed by Holm-Sidak post-hoc test, p < 0.0001). 
(G) Experimental protocol for conditioned place aversion (CPA). Each session comprises 20 min in the CPA box. 
(H-I). Photostimulation of elPBN efferent terminals in the CEA (H) or BNST (I) induces CPA. Data are from 
individual animals (n = 11 - 12 mice per group). * indicates significantly different (Paired Student’s t-test: CEA: p = 
0.025; BNST: p = 0.028).  
(F) Entries into photostimulation chamber upon photostimulation of elPBN efferent terminals in the CEA terminals. 
** indicates change in entry number between test phase and habituation phase is significantly different between eYFP 
and ChR2 mice (unpaired Student’s t-test, p = 0.003).  
(J) Summary diagram depicting behavioral responses observed upon stimulation of elPBN outputs to BNST and 
CEA.  
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Similar to our previous experiment to dissect circuit function of dPBN outputs, we verified 
the specificity of elPBN circuit photoactivation (Figure 9). 
  
Figure 11 Optogenetic stimulation of lPBN efferents on aversive memory. 
(A-B) Optogenetic activation of terminals in VMH (A) or lPAG (B) of ChR2-injected mice does not cause 
CPA (paired Student’s t-test: VMH: p = 0.605; lPAG: p = 0.986). Data are from individual mice (n = 7 – 9 
mice per condition).  
(C-E) Optogenetic activation of ChR2-expressing efferents terminals in BNST (C), VMH (D), or lPAG (E) 
does not affect the number of entries into the photostimulation chamber during RTPA (Student’s t-test, 
BNST: p = 0.942; VMH: p = 0.772; lPAG: p = 0.219). Data are mean ± SEM and dots represent data points 
from individual animals (n = 9 - 11 mice per group).  
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3.4 Discussion 
In this chapter we devised experiments to determine the function encoded within divergent 
pathways emanating from the lPBN. Our optogenetic experimentation demonstrated drastically 
different effects on animal behavior. Projections to VMH and lPAG arise from dPBN, and the 
photoactivation of these projections resulted in behaviors that permit withdrawal or escape from a 
potentially noxious stimuli, as indicated by stimulus-locked increases in jumping, running, and/or 
endogenous analgesia. On the other hand, photostimulating elPBN axon terminals within BNST 
or CEA resulted in CPA learning. These data suggest that the cytoarchitecturally distinct domains 
of lPBN, although together respond to noxious stimuli, may mediate different aspects of 
nociceptive information to forebrain regions and consequently underlie behaviorally distinct 
aspects of the pain response.  
An interesting finding is that, although lPBN comprises distinct subdomains, the 
photoactivation of any lPBN output resulted in real time place aversion. Whereas previous studies 
have focused on elPBN neurons, and particular those expressing CGRP, our data suggest that the 
lPBN serves as a hub to relay unpleasantness of either interoceptive or exteroceptive signals, at 
least in real time, through downstream forebrain regions. Notably, dPBN outputs failed to elicit 
aversive learning through CPA despite dramatic real time avoidance behavior. These indicate that 
the repeated photostimulation as our conditioning stimulus failed to recruit downstream 
mechanisms in either VMH or lPAG capable of driving learned behavior (Kunwar et al., 2015). 
On the other hand, repeated optogenetic activation of elPBN projections to BNST and CEA 
sufficiently developed an aversive memory. Although the specific mechanisms through which this 
occurs in BNST remain unclear (Davis et al., 2010; Lebow and Chen, 2016), this likely occurs 
through synaptic plasticity of CGRPR, somatostatin-expressing neurons, and other unidentified 
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genetic cell types in the CEA (Ciocchi et al., 2010; Han et al., 2015a; Li et al., 2013; Sato et al., 
2015). Additional studies that identify the postsynaptic targets of these projections are warranted 
to better understand the mechanisms through which aversive learning occurs. 
In contrast, little work has been done to elucidate the functional contributions of dPBN to 
nociception. Whereas previous studies of the physiological function of dPBN have revealed 
genetically-defined subsets involved in fluid satiation and thermoregulation (Nakamura and 
Morrison, 2008, 2010; Ryan et al., 2017), our findings demonstrate that the activity of dPBN 
outputs underlie robust locomotor behavior, suggesting the possibility that noxious stimuli may 
recruit these dPBN pathways to drive motivated behaviors to withdraw from potential injury. This 
is consistent with previous findings in which at least a subset of dPBN neurons preferentially 
respond to diverse noxious sensations, such as mechanical (in the form of a pinch) or thermal 
(burning heat) stimuli (Bernard et al., 1994; Bester et al., 1997; Hermanson and Blomqvist, 1996, 
1997; Nakamura and Morrison, 2010). Interestingly, the optogenetic activation of dPBN terminals 
in VMH resulted in similar but disparate locomotor actions compared to that in lPAG despite 
prominent collateralizations to these two targets. This finding raises the possibility that, as is the 
case with elPBN collaterals to BNST and CEA, the evolutionary need to survive a life-threatening 
stimulus has developed redundant pathways to ensure an organism’s survival. Alternatively, each 
collateral may relay nuanced aspects of the neural encoding of a threat such that the subtle 
differences in behaviors manifest from the coordinated activity of different downstream targets. 
Consistent with this idea, both VMH and lPAG have been shown to mediate different aspect of 
defensive behaviors such as running, jumping, and freezing (Kunwar et al., 2015; Tovote et al., 
2016; Wang et al., 2015). Specific to terminal stimulation within lPAG, optogenetic activation 
resulted in increased endogenous analgesia likely through opioid-dependent mechanisms via the 
 57 
rostroventral medulla and spinal cord (Basbaum and Fields, 1984; McGaraughty et al., 2004; 
Roeder et al., 2016). 
A noteworthy observation is that the optogenetic activation of dPBN pathways elicited 
escape-like behaviors independent of a noxious stimulus, indicating that these behaviors reflect 
innate motor responses rather than the enhancement of a nocifensive response, as seen in other 
lPBN projections to brainstem (Barik et al., 2018). This suggests that a wide modality of stimuli 
capable of recruiting dPBN circuits may drive escape-like responses via the dPBN projections 
characterized in our experiments. This is not inconsistent with previous studies demonstrating that 
lPBN also serves significant roles in promoting arousal and inhibiting consummatory behaviors 
(Kaur et al., 2013; Kaur et al., 2017; Ryan et al., 2017), as an animal’s ability to exhibit locomotor 
actions requires an increased state of arousal and reduction in feeding behavior. However, as a 
result of technical considerations we were unable to determine the role of divergent lPBN 
pathways on autonomic regulation of respiration and cardiovascular function in awake, behaving 
animals, a topic on which we speculate in our Conclusion.  
Although our experiments provide evidence that dPBN and elPBN efferents primarily 
elicited distinct behavioral repertoires, we acknowledge that such a model undoubtedly 
oversimplifies the complex and interconnected circuitry underlying these behaviors. Despite 
optogenetic activation of axon terminals at a given downstream target, multiple brain regions from 
our manipulation are likely to have been indirectly affected. For example, both BNST and CEA 
exhibit reciprocal connections with each other as well as the lPBN and other brain regions (Barik 
et al., 2018; Rodriguez et al., 2017; Tokita et al., 2009). Consistent with this interconnectivity, we 
found that photostimulation of a single efferent pathway activates multiple brain regions, as 
evidenced by Fos induction. It is therefore not surprising that some behaviors were not completely 
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specific to the photoactivation of a particular lPBN projection. Most notably, stimulation of 
efferents to the BNST elicited small but significant escape-like responses, as measured by 
increases in running and endogenous analgesia, as well as CPA learning. Nevertheless, the broad 
findings of our experiments in this Chapter are consistent with a modular output from the lPBN 
that would enable the coordination of nocifensive responses in a context-dependent manner.  
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4.0 Role of dynorphin lateral parabrachial neurons in the pain experience 
4.1 Introduction 
The lPBN has been implicated in numerous autonomic regulatory roles such as arousal, 
respiration, cardiovascular responses, and feeding (Benarroch, 2016, 2018; Davern, 2014). 
However, the identity of lPBN neurons underlying these physiological functions has yet to be 
determined. The genetic identity of lPBN populations regulating thermosensation has been 
characterized in minor detail. dPBN neurons expressing dynorphin (PdynCre) respond more 
strongly to warmth, whereas cooling activates a subset of FoxP2-positive elPBN neurons (Geerling 
et al., 2016). Regardless, the convergence of both interoceptive and exteroceptive signals into 
lPBN likely engages lPBN circuits that integrate these signals to coordinate appropriate behavioral 
and autonomic responses.  
To our knowledge, we are the first to perform experiments that investigated how the 
activation of PdynCre neurons affects nocifensive behavior. First, we designed experiments to 
identify anatomical connections between PdynCre neurons and spinoparabrachial neurons. We then 
performed optogenetic experiments to determine whether activation of these neurons were 
sufficient to elicit the nocifensive behaviors characterized in the previous Chapter. Finally, we 
selectively ablated these neurons in adult mice to determine the necessity of these neurons in 
nocifensive behaviors. 
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4.2 Methods 
4.2.1  Animals 
Mice were given free access to food and water and housed under standard laboratory 
conditions. The use of animals was approved by the Institutional Animal Care and Use Committee 
of the University of Pittsburgh. Pdyn-IRES-Cre (Krashes et al., 2014), Sst-cre ((Taniguchi et al., 
2011) stock: 013044), Calb2-cre ((Taniguchi et al., 2011) stock: 010774), Crh-cre (Taniguchi et 
al., 2011) stock: 012704), and Nts-cre ((Leinninger et al., 2011) stock: 017525) were obtained 
from Jackson Laboratories.Wild-type C57BL/6 mice were obtained from Charles River (Cat # 
027). For all experiments 8 – 16 week-old male and female mice were used. In all cases, no 
differences between male and female mice were observed and so the data were pooled. 
4.2.2  Viruses 
The following viruses were used for experimentation: AAV2-hsyn-eYFP (Addgene: 
50465), AAV2-EF1a-DIO-eYFP (Addgene: 27056), AAV2-EF1a-DIO-hChR2(H134R)-eYFP 
(Addgene: 20298), AAV9-CAGGS-FLEX-ChR2-tdtomato.WRPE.SV40 (Addgene: 18917), 
AAV2-EF1a-flex-taCasp3-TEVp (Addgene: 45580), AAV8.2-hEF1a-DIO-synaptophysin-eYFP 
(MGH: AAV-RN2), AAV8.2-hEF1a-DIO-PSD95-eYFP (MGH: AAV-RN7), and AAV8.2-
hEF1a-synaptophysin-mCherry (MGH: AAV-RN8). Viruses were purchased from University of 
North Carolina Vector Core, University of Pennsylvania Vector Core, and Massachusetts Gene 
Technology Core. 
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4.2.3  Stereotaxic injections and optical fiber implantation 
Stereotaxic injections and optical fiber implantations were performed as described in the 
previous chapter. Mice were bilaterally injected with 0.5 l virus. The injection needle was left in 
place for an additional 5- 10 min and then slowly withdrawn. Injections and optical fiber 
implantations were performed bilaterally in the lPBN at AP -5.11 mm, ML ± 1.25 mm, DV: -3.25. 
For implantation of optical fibers (Thor Labs: 1.25 mm ceramic ferrule 230 m diameter), implants 
were slowly lowered 0.300-0.500 mm above the site of injection and secured to the skull with a 
thin layer of Vetbond (3M) and dental cement. The incision was closed using Vetbond and animals 
were given a subcutaneous injection of buprenorphine (0.3 mg/kg) and allowed to recover over a 
heat pad. Mice were given 4 weeks to recover prior to experimentation. 
4.2.4  Intraspinal injections 
Mice were anesthetized with 100 mg/kg ketamine and 10 mg/kg xylazine. An incision was 
made at the spinal cord level corresponding to L4-6 spinal level. The intrathecal space was 
exposed, and two injections of approximately 0.5 l of virus was infused 300 m below the surface 
of the spinal cord at 100 nL/min via glass pipette through the intrathecal space corresponding to 
L4-6 of the spinal cord. The glass pipette was left in place for an additional 5 minutes before 
withdrawal. The incision was closed with 5-0 vicryl suture. Buprenorphine was delivered post-
surgery at 0.3 mg/kg subcutaneously, and mice were allowed to recover over a heat pad.  
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4.2.5  Immunohistochemistry 
Immunohistochemistry was performed as previously described in Chapters 2 and 3. 
Primary antisera (rabbit anti-Homer1 at 1:1K) were incubated for 3 days at 4°C. 
4.2.6  RNAscope in situ hybridization 
Multiplex fluorescent in situ hybridization was performed according to the manufacturer’s 
instructions (Advanced Cell Diagnostics #320850). Briefly, 18 m-thick fresh-frozen sections 
containing the parabrachial nucleus were fixed in 4% paraformaldehyde, dehydrated, treated with 
protease for 15 minutes, and hybridized with gene-specific probes to mouse Pdyn (#318771), 
Calca (417961), Tac1 (410351), Gad2 (415071), Fos (316921), Slc32a1 (#319191), and Slc17a6 
(#319171). DAPI (#320858) was used to visualize nuclei. 3-plex positive (#320881) and negative 
(#320871) control probes were tested. Two to three full-tissue z-stacked sections were quantified 
for a given mouse, and 2 – 4 mice were used per experiment.  
4.2.7  Image acquisition and analysis 
Full-tissue thickness sections were imaged using either an Olympus BX53 fluorescent 
microscope with UPlanSApo 4X, 10X, or 20X objectives or a Nikon A1R confocal microscope 
with 20X or 60X objectives. All images were quantified and analyzed using ImageJ. To quantify 
images in RNAscope in situ hybridization experiments, confocal images of tissue samples (1 – 2 
sections per mouse over 2 – 4 mice) were imaged and only cells whose nuclei were clearly visible 
by DAPI staining and exhibited fluorescent signal were counted. 
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4.2.8  Behavior 
Behavior was performed as previously described in Chapter 3. 
Diffuse noxious inhibitory control (DNIC) testing 
To induce DNIC, 0.1% 10 l capsaicin solution was administered into the hindpaw, and 
mice were subsequently tested for tail flick latency 20 minutes post-injection at 55°C as described 
during the tail immersion test. 
4.2.9  Statistical analysis 
Statistical analysis was performed as previously described in Chapter 3. 
4.3 Results 
Having examined the outputs from the lPBN that could mediate the behavioral responses 
to noxious stimuli, we next characterized the nociceptive inputs to this nucleus. Towards this end, 
we used the Tacr1CreER allele (Huang et al., 2016) to visualize neurokinin 1 receptor-expressing 
spinoparabrachial neurons (NK1R+ SPbN), which are known to transmit noxious signals from the 
spinal cord to the brain (Cameron et al., 2015; Todd, 2010). To visualize the innervation of the 
lPBN by these neurons, an AAV encoding a Cre dependent fluorescent reporter was injected into 
the L4-L6 spinal cord region of Tacr1CreER tamoxifen-inducible Cre mice (Figure 12A). We found 
that Tacr1CreER neurons showed dense innervation of the lPBN that was regionally constrained, 
with the vast majority of these terminals targeting the dPBN and very few targeting the elPBN 
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(Figure 12B and 12C), consistent with previous studies (Harrison et al., 2004). To ensure that this 
observation was not specific to Tacr1CreER neurons, we repeated this experiment using a 
constitutive AAV to label all spinoparabrachial neurons. Again, we saw the same distribution of 
input from the spinal cord, which was predominant in the dPBN, but not the elPBN (Figures 12D 
and 12E).  
The paucity of direct nociceptive input to the elPBN was somewhat curious to us in light 
of previous studies that showed direct innervation of elPBN neurons by spinoparabrachial neurons 
(Cechetto et al., 1985; Feil and Herbert, 1995; Ma and Peschanski, 1988). Indeed, we found that 
both the dPBN and elPBN subregions showed significant Fos induction in response to noxious 
stimulation induced via capsaicin treatment of the hindpaw (Figures 12F and 12G), consistent with 
previous results (Bernard et al., 1994; Hermanson and Blomqvist, 1996). However, the presynaptic 
terminals of Tacr1CreER spinoparabrachial neurons were only observed in close apposition to Fos+ 
neurons within the dPBN (Figure 12H).   
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Figure 12 Spinoparabrachial input is concentrated in dPBN, but noxious stimulation drives Fos expression in 
both dPBN and elPBN. 
(A) Experimental strategy to visualize spinal inputs into lPBN. An AAV encoding Cre- dependent eYFP (green) 
or constitutive eYFP (pseudocolored pink) was injected into the spinal cord (L4-L6) in Tacr1
CreER 
or WT mice.  
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The apparent discrepancy between the localized nature of the nociceptive input in the 
dPBN and the widespread nature of the Fos induction by intraplantar capsaicin raised the question 
of how noxious information reaches the elPBN. With the goal of identifying a neuronal population 
that might convey nociceptive information between lPBN subregions, we investigated cell types 
that are known to be expressed in the dPBN using a combination of Cre alleles and stereotaxic 
(B-C) Representative image (B) and quantification (C) of the innervation density of efferent terminals in the lPBN 
from NK1R+
 
spinoparabrachial neurons (SPbN). Data are mean ± SEM and dots represent data points from 
individual animals (n = 3 mice). * indicates area of SPbN projections to dPBN (as percent of region) is significantly 
greater than that to elPBN (Paired Student’s t-test; p = 0.036). Scale bar = 100 m. 
(D-E) Representative image (D) and quantification (E) of the innervation density of efferent terminals in the lPBN 
from all spinoparabrachial neurons. Data are mean ± SEM and dots represent data points from individual animals 
(n = 4 mice). * indicates area of spinoparabrachial projections to dPBN (as percent of region) is significantly greater 
than that to elPBN (Paired Student’s t-test; p = 0.0094). Scale bar = 100 m.  
(F-G) Representative image (F) and quantification (G) of Fos induction in the dPBN and elPBN in response to 
intraplantar saline (10 l) or capsaicin (10 l, 0.03%). Data are mean ± SEM and dots represent data points from 
individual animals (n = 4 - 5 mice per group). Asterisks indicate significantly different (Two-way RM ANOVA 
followed by Tukey’s post-hoc; * p < 0.05; **** p < 0.001.) Scale bar = 100 m.  
(H) NK1R+
 
spinoparabrachial terminals (visualized through viral expression of eYFP) are found in close apposition 
to Fos+ cells in the dPBN following intraplantar capsaicin. Image is representative of data from 4 mice. Scale bar 
= 25 m. 
(I) Representative image and quantification of Pdyn
Cre 
expressing neurons in the dPBN and elPBN as visualized 
by FISH (n = 4 mice). Scale bar = 100 m; inset: 25 m.  
(J) Pdyn
Cre 
neurons in dPBN project to elPBN. AAV encoding Cre-dependent ChR2 was injected into lPBN of 
Pdyn
Cre 
mice to visualize projection. Images are representative of data from at least 4 mice. Scale bar = 100 m; 
inset: 25 m. 
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injection of Cre dependent AAV reporters to visualize these cells and their projections. In total, 
six alleles were screened: SstCre; Tacr1CreER, NtsCre, Calb2Cre, CrhCre and PdynCre alleles. Although 
all of these genetic tools uncovered populations of neurons with subregion-specific expression in 
the lPBN (Figure 13), only dynorphin-expressing neurons exhibited unique anatomical 
characteristics that positioned them to convey noxious information from the dPBN to the elPBN. 
In particular, using dual fluorescent in situ hybridization (FISH), we found Pdyn neurons were 
located almost exclusively in the dorsal region of the lPBN (Figure 12I), consistent with previous 
studies (Geerling et al., 2016). Next, we validated the PdynCre allele, confirming that Cre-
dependent AAV viruses injected into the lPBN of these mice selectively targeted Pdyn-expressing  
Figure 13 Screen of putative cell-type specific lPBN subpopulations 
AAV encoding a fluorescently-tagged channelrhodopsin (0.5l, bilateral) was injected into the lPBN of the 
following genetic mice harboring knock-in alleles for Cre-recombinase: (A) Somatostatin (Sst-cre, Taniguchi et al. 
2011). (B) Calretinin (Calb2-cre, Taniguchi et al. 2011). (C) Corticotropin releasing hormone (Crh-cre, Taniguchi 
et al. 2011). (D) Neurokinin-1 receptor (Tacr1-creER, Huang et al. 2016). (E) Neurotensin (Nts-cre, Leinninger et 
al. 2011). Scale bar = 200 m (A - E).  
 68 
neurons (Figure 15A). Finally, using this allele to visualize dynorphin-expressing neurons, we 
found that dynorphin neurons in dPBN project to the elPBN (Figure 12J). Thus, dynorphin- 
expressing neurons have cell bodies in the dPBN and send prominent projections to the elPBN.  
To further investigate the putative role of dynorphin neurons in nociceptive processing, we 
used a viral strategy to determine whether spinoparabrachial neurons directly innervate the PdynCre 
subset of dPBN neurons. PdynCre mice were stereotaxically injected with AAV encoding a Cre-
dependent PSD95-eYFP into the lPBN and another encoding a constitutive synaptophysin-
tdtomato into the spinal cord (Figure 14A). These efforts revealed presynaptic terminals from 
spinal output neurons that were in close apposition to PSD95-eYFP in PdynCre neurons, suggestive 
of direct synaptic contacts. Moreover, we found that intraplantar injection of capsaicin gave rise 
to strong Fos induction in PdynCre neurons. Specifically, 75% of Fos-expressing cells belonged to 
the PdynCre population and Fos was induced in 50% of these cells (Figure 14B). Together, these 
data provide anatomical and functional evidence that PdynCre neurons in the dPBN receive noxious 
input via spinoparabrachial neurons.  
To characterize these PdynCre neurons in more detail, we next examined whether this 
population represented an excitatory or inhibitory population of neurons through dual fluorescent 
in situ hybridization (FISH). We found that nearly all Pdyn transcript colocalized with Slc17a6 
(Vglut2), with Pdyn cells representing approximately one-quarter of the excitatory population 
within the dPBN (Figure 14C). In contrast, there was very little to no overlap of Pdyn and the 
inhibitory marker Slc32a1 (Vgat) (Figure 15B). Thus, from a neurochemical standpoint, dynorphin 
neurons in the dPBN are positioned to relay nociceptive information to the elPBN.  
To further investigate whether dynorphin neurons could provide a cellular substrate for 
transmission of nociceptive information to elPBN efferents, we used viral and retrograde tracing 
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approaches to determine whether PdynCre neurons form anatomical connections with elPBN 
neurons that project to CEA and BNST. Towards this end, we stereotaxically injected AAV 
encoding a Cre-dependent synaptophysin-eYFP into dPBN together with CTB into either the CEA 
or BNST of PdynCre mice (Figure 14D). These experiments suggested that approximately two- 
thirds of CTB-labeled cells from either the BNST or the CEA receive synaptic input from PdynCre 
neurons as supported by the close apposition of retrogradely labeled cells to synaptophysin-eYFP 
and the post-synaptic density marker Homer1 (Figures 14E and 14F). These data provide 
anatomical support for the idea that PdynCre neurons may convey noxious information to neurons 
in the elPBN that have efferent projections to the CEA and/or BNST.  
To further test the idea that PdynCre neurons in the dPBN convey information to the elPBN, 
we next examined whether activation of this population is sufficient to elicit the behavioral 
responses that are mediated by elPBN efferents. To manipulate these cells, we delivered an AAV 
encoding Cre-dependent ChR2 or eYFP into the lPBN of PdynCre mice. Consistent with our 
hypothesis, we found that photostimulation of PdynCre neurons in the lPBN mice gave rise to 
aversive behaviors, but not escape behaviors. In particular, optogenetic stimulation resulted in real 
time place aversion coupled with a significant reduction in number of entries into the stimulation 
chamber (Figures 14G and 14H). In contrast, the activation of PdynCre neurons had no effect on 
escape behaviors including running, jumping or tail flick latency (Figures 15C, 15D and 15E). The 
optogenetic activation of PdynCre neurons in lPBN provide behavioral data to support the idea that 
these neurons convey noxious information to elPBN neurons that project to downstream forebrain 
areas. To confirm our behavioral observations, we stereotaxically delivered virus encoding a 
genetically engineered caspase 3, a protease that induces programmed cell death 
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Figure 14 Dynorphin-expressing neurons may convey nociceptive input from dPBN to elPBN 
(A) Spinoparabrachial synaptic inputs are found in close apposition to postsynaptic terminals of dynorphin neurons 
in dPBN. Pdyn
Cre 
mice were injected with AAVs encoding a Cre-dependent PSD95-eYFP in the lPBN and 
constitutive synaptophysin-tdtomato in the spinal cord (L4-L6). Image is representative of data from 2 mice. 
(B) Pdyn
Cre
 cells express Fos following in response to noxious stimulation. An AAV encoding Cre-dependent 
eYFP was stereotactically injected into the lPBN to visualize dynorphin+ cells. Mice received intraplantar 
injections of capsaicin (10 l, 0.03%). Representative image and quantification of the colocalization of Fos+ 
neurons and Pdyn
Cre
 neurons, as visualized by expression of eYFP. Data are mean ± SEM and dots represent data 
points from individual animals (n = 4 mice). Scale bar = 25 m; inset: 5 m. 
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(Yang et al., 2013). Through this approach, we ablated the adult population of PdynCre neurons in 
lPBN and subsequently tested whether the loss of these neurons prevented mice from developing 
an aversive memory to a painful stimulus. Caspase-injected mice exhibited dramatically fewer 
PdynCre neurons compared to eYFP-injected mice (Figure 16A and 16B). To determine whether 
ablating this specific lPBN subpopulation would block the development of an aversive memory, 
we tested mice in a CPA assay in which mice were conditioned to intraplantar injection of 
formalin. Before conditioning, both control and caspase-injected mice spent similar amounts of 
time in the conditioned chamber. However, following two consecutive days of formalin 
conditioning, only control mice exhibited a significance reduction in the time spent in the  
  
 (C) Dynorphin cells are primarily excitatory. Representative image and quantification of colocalization between 
Pdyn
Cre
 and Slc17a6 mRNA in dPBN, as observed by dual FISH. Data are mean ± SEM and dots represent data 
points from individual animals (n = 3 mice). Arrows denote neurons with colocalized signal. Scale bar = 25 m. 
(D) Experimental strategy to visualize Pdyn
Cre
 synaptic inputs onto elPBN efferents that project to BNST or CEA. 
CTB was injected into either the BNST or the CEA and Cre-dependent synaptophysin-eYFP was delivered into 
the lPBN of Pdyn
Cre
 mice. 
(E-F). Synaptic terminals from Pdyn
Cre
 neurons (green) are in close apposition to Homer1 puncta (purple) 
surrounding CTB-labeled neurons that have been backlabeled from the BNST (E; red) or CEA (F; blue). Data 
are mean ± SEM and dots represent data points from individual animals (n = 4 mice per experiment).  
(G) Photostimulation of ChR2-expressing Pdyn
Cre
 cells in the dPBN elicits real time place aversion. Data are 
mean ± SEM and dots represent data points from individual animals (n = 9 – 11 mice per group). **** indicates 
significantly different (Two-way RM ANOVA followed by Holm-Sidak post-hoc test, p < 0.0001). 
(H) Photostimulation of ChR2-expressing Pdyn
Cre
 cells in the dPBN significantly diminished entry number into 
the stimulation chamber. Data are mean ± SEM and dots represent data points from individual animals (n = 9 – 
11 mice per group). **** indicates significantly different (unpaired Student’s t-test p < 0.0001).  
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Figure 15 Analysis of Pdyn neurons in the lPBN and the effects of optogenetic activation. 
(A) Representative image (left) and quantification (right) of lPBN in PdynCre mice injected with an AAV 
encoding Cre-dependent eYFP into the lPBN and subsequently analyzed by dual FISH using probes targeting 
Pdyn and eYFP. Data are mean and dots represent data points from individual animals (n = 2 mice).  
(B) Representative image (left) and quantification (right) of the lPBN using dual FISH with probes targeting 
Pdyn and Vgat. Data are mean and dots represent data points from individual animals (n = 3 mice).  
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conditioned chamber (Figure 16C). These data suggest that the loss of PdynCre neurons prevents 
CPA learning. 
Next, we tested whether the loss of PdynCre neurons specifically precluded the ability to 
develop an aversive memory and not other behavioral outputs related to escape behaviors. To 
address this, we injected a capsaicin solution into the hindpaw of control and caspase-injected mice 
to determine whether PdynCre neurons mediate diffuse noxious inhibitory control (DNIC), a form 
of descending modulation that is mediated in part through lPAG projections to brainstem (Le Bars, 
2002; Ossipov et al., 2010). Both control and caspase-injected mice exhibited no differences in 
their tail flick latencies at either baseline or following capsaicin injection (Figure 16D). 
Importantly, both groups exhibited an increase in their tail flick latencies following capsaicin 
injection, indicating the recruitment of DNIC in response to hindpaw capsaicin administration 
(51.3 ± 12.6% vs. 70.1 ± 12.6%, control vs. caspase-treated mice, respectively). Thus, these mice 
exhibited an intact DNIC response despite the ablation of PdynCre neurons within lPBN. 
The observation that caspase-treated PdynCre mice exhibited impaired CPA learning but 
not a DNIC response to a noxious stimulus suggests that PdynCre neurons may indeed be conveying 
noxious input from dPBN to neurons within elPBN, consistent with our anatomical data (Figure 
14E and 14F). To further test this, we determined whether delivering intraplantar capsaicin in 
(C) Optogenetic stimulation of ChR2-expressing PdynCre neurons in lPBN does not induce lateral locomotion (two-
way RM ANOVA followed by Holm-Sidak post-hoc test, F (5, 90) = 17.21).  
(D) PdynCre ChR2-injected mice do not jump when photostimulated.  
(E) Optogenetic stimulation of ChR2-expressing PdynCre neurons in lPBN does not increase tail flick latency at 48°C 
(two-way RM ANOVA, F (1, 18) = 0.6300) or 55°C (two-way RM ANOVA, F (1, 18) = 0.004203) compared to 
control mice. Data represent mean ± SEM. Scale bar = 50 m (A - B)  
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control and caspase-treated PdynCre mice would recruit neurons within elPBN through the 
induction of Fos. Recent studies have demonstrated the significance of CGRP- and Tac1-
expressing elPBN neurons on pain-related behaviors (Barik et al., 2018; Campos et al., 2018). We 
therefore focused on Fos expression within these two elPBN subsets. In control mice, intraplantar 
capsaicin administration induced Fos in 16.3 ± 1.8% of Calca-positive neurons (Figure 17A and 
17B). However, this proportion was significantly reduced in mice in which PdynCre were ablated 
(10.3 ± 1.9%, p = 0.04, n = 5 – 7 mice per group). We observed no difference in the proportion of 
Tac1 elPBN neurons expressing Fos in control and PdynCre - ablated mice (Figure 17C and 17D). 
These data highlight that PdynCre neurons serve a crucial link for the recruitment of elPBN 
pathways to CEA and BNST (Figure 18).  
 
Figure 16 Ablating Pdyn+  lPBN neurons abrogates CPA but not DNIC. 
(A) Visualization of Pdyn+ lPBN neurons in control and caspase-injected mice. (B) Caspase-injected mice exhibited 
significantly fewer PdynCre neurons compared to control mice. Data are mean ± SEM and dots represent data points 
from individual animals (unpaired Student’s t test, p < 0.0001, n = 9 – 12 mice per group). (C) Ablating PdynCre 
neurons prevents CPA compared to control mice (paired Student’s t test, Control: p = 0.016, n = 11 – 12 mice per 
group). (D) The withdrawal latency during capsaicin-induced DNIC to a tail flick test was not significantly different 
compared to that in control mice. (two-way RM ANOVA, F (1, 16) = 0.551, n = 8 – 10 mice per group). 
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(A) Representative images of Fos expression in Calca elPBN subpopulations between control vs. caspase-
injected mice. 
(B) Ablation of PdynCre neurons in dPBN reduces the number of Fos expressing-Calca neurons in elPBN 
following intraplantar injection of capsaicin. (unpaired Student’s t-test, p = 0.044, n = 5 – 7 mice). 
(C) Representative images of Fos expression in Tac1 elPBN subpopulations between control vs. caspase-
injected mice. 
(D) Ablation of PdynCre neurons in dPBN does not reduce the number of Fos-expressing Tac1 neurons in elPBN 
following intraplantar injection of capsaicin. (unpaired Student’s t-test, p = 0.154, n = 5 – 7 mice). 
Figure 17 Effect of ablating dynorphin-expressing  neurons on Fos expression in elPBN subpopulations. 
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4.4 Discussion 
In this final Chapter, we present data supporting the idea that dynorphin-expressing 
neurons within dPBN relay noxious input arising from the periphery onto elPBN-projecting 
neurons, thus coordinating the generation of a nocifensive response at the level of the lPBN. 
Noxious stimuli induce Fos expression in both dPBN and elPBN. However, only dPBN Fos+ 
neurons are in close apposition to NK1R+ spinoparabrachial neurons. We demonstrate that the 
majority of Fos expression occurs within the PdynCre subset, and that these neurons extend 
processes directly onto BNST- and CEA- projecting neurons within elPBN. Despite their cell 
bodies being located within dPBN, optogenetic activation of dynorphin-positive neurons elicits an 
aversive memory with no effect on escape-like behaviors such as increased running, jumping, or 
recruitment of endogenous analgesia. Complementary results through the ablation of this 
genetically-defined population show that loss of these neurons impairs CPA learning. Furthermore, 
elPBN CGRP- and Tac1-expressing neurons of mice lacking dPBN dynorphin neurons exhibit 
diminutions in Fos expression in response to noxious stimulation as revealed by FISH analysis, 
supporting the role of dynorphin neurons in communicating across lPBN territories.  
Spinoparabrachial neurons expressing the NK1R have been reported to terminate in the 
lPBN (Cameron et al., 2015; Cechetto et al., 1985; Harrison et al., 2004; Hylden et al., 1989; 
McMahon and Wall, 1985; Panneton and Burton, 1985). However, the neural population receiving 
these nociceptive inputs remain unclear. It is likely that the neurons receiving this direct input 
compose a heterogeneous group that underlie different autonomic and behavioral responses. The 
PdynCre and Tacr1CreER populations that we visualized in our tracing studies consist of spatially 
separate populations that reside within the terminal fields of NK1R+ spinoparabrachial neurons. 
Furthermore, the dendritic and axonal extensions as well as projection patterns to downstream 
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brain regions appear vastly different between PdynCre and Tacr1CreER neurons, arguing that these 
genetically defined populations represent discrete dPBN subpopulations. Further characterizations 
of the degree of overlap are warranted to confirm this. In addition, we suggest that the PdynCre 
population receive direct input from NK1R-positive spinoparabrachial neurons. However, it is 
unlikely to be the only subpopulation that receives this monosynaptic input. Tacr1CreER neurons 
are within the terminal fields of these spinoparabrachial neurons, but whether these populations 
receive direct input from the spinal cord remains debatable. Thus, electrophysiology recordings 
are needed to confirm functional synapses between spinoparabrachial neurons expressing NK1R 
and their downstream targets, such as the PdynCre and/or Tacr1CreER populations. A recent study 
demonstrated that a subset of spinoparabrachial neurons form monosynaptic connections with 
dPBN but not elPBN neurons (Huang et al., 2018). Thus, it is possible that these neurons make up 
a part of the PdynCre or Tacr1CreER subsets.  
Moreover, the morphology of the PdynCre and Tacr1CreER populations appear to span 
cytoarchitectural boundaries, suggesting the possibility that these neurons may engage in trans-
domain communication to convey noxious information among adjacent subnuclei, for example to 
neurons within the elPBN such as those expressing CGRP (Bourgeais et al., 2001; Hayward and 
Felder, 1999; Herbert and Bellintani-Guardia, 1995). Consistent with this anatomy, our data reveal 
that only the PdynCre neurons have cell bodies in the dPBN and send extensive projections to the 
elPBN. This does not preclude the possibility that elPBN neurons extend dendritic arbors dorsally 
into dPBN subdivisions (Bourgeais et al., 2003; Chamberlin et al., 1999). However, the dendritic 
domains of most elPBN neurons were found to remain cytoarchitecturally confined to the elPBN, 
and the relationship between those that exhibit dendritic arbors within dPBN and their response to 
noxious stimuli remain unclear. In addition, we find that PdynCre neurons are activated by noxious 
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input and drive aversion, but not escape behaviors. However, we note that this is unlikely to be the 
only function of PdynCre cells in the lPBN because these neurons have been shown to play 
important roles in temperature homeostasis (Geerling et al., 2016; Nakamura and Morrison, 2008, 
2010). These findings raise the possibility that PdynCre neurons in the lPBN are not a single, 
homogeneous population. Indeed, we observed prominent projections to downstream targets 
including the dorsomedial hypothalamus (DMH) and lPAG. As we previously found that dPBN 
neurons collateralize to VMH and lPAG, we believe that the PdynCre population does not compose 
those that collateralize to these two targets. Furthermore, optogenetic stimulation of dPBN PdynCre 
terminals in lPAG or DMH failed to elicit running, jumping, or descending modulation (data not 
shown), suggesting that the observed behaviors following optogenetic stimulation of PdynCre lPBN 
neurons arose through the circuit manipulation of local lPBN activity, namely those between dPBN 
and elPBN neurons. In future studies, it will be important to characterize this heterogeneity in more 
detail to identify bona fide cell types and characterize how each defined population responds to 
diverse stimuli. For example, determining the sufficiency and requirement of PdynCre lPBN 
neurons and their projections to DMH or lPAG in a variety of thermal challenges, such as a thermal 
place preference assay, would help delineate this population in greater detail. 
A noteworthy finding through our optogenetic activation of PdynCre neurons is the 
reduction in locomotor activity following photostimulation. A previous study showed that 
activating CGRP-expressing neurons in elPBN resulted in reversibly induced freezing with 
increases in basal immobility; stimulating downstream CEA neurons expressing the CGRP 
receptor (CGRPR) resulted in gradually increasing freezing behavior over several minutes 
(Han_Palmiter_2015). Thus, one possible explanation for the freezing behavior observed 
following PdynCre stimulation is the recruitment of the CGRP lPBN projections to CGRPR CEA. 
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Consistent with this interpretation, ablating PdynCre neurons reduces Fos expression in CGRP 
lPBN neurons following exposure to a noxious stimulus. However, we would have expected to 
observe freezing behavior following terminal activation of elPBN projections to CEA. The CEA 
comprises heterogeneous populations underlying divergent behavioral repertoires (Kim et al., 
2017). Our terminal stimulation may therefore have targeted several of these populations which 
resulted in no overt freezing behavior. Future experiments would help elucidate the different 
postsynaptic targets of PdynCre neurons, the heterogeneity of cell types within lPBN, and their 
interactions that underlie the nociceptive response. 
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5.0 Conclusion 
This study investigated the neural pathways of lPBN neurons emanating from spatially 
discrete regions that target different downstream regions and encode different components of a 
nocifensive response. We used genetic approaches to visualize and characterize these pathways. 
Furthermore, we manipulated the activity of these divergent projections using optogenetic and 
chemogenetic approaches. Our visualization of lPBN populations revealed a unique subset of 
lPBN neurons that spanned cytoarchitectural boundaries and mediated sensory input from spinal 
cord to forebrain-projecting elPBN neurons to elicit aversive learning. Our experiments provide a 
framework for future studies to better understand more broadly how different lPBN populations 
contribute to physiological responses to potentially threatening stimuli. 
Our first step in this collection of experiments demonstrated the significance of lPBN 
activity to exhibit a nocifensive response to mechanical hypersensitivity. Next, we characterized 
the efferent pathways from two distinct lPBN populations: those arising from dPBN collateralize 
to VMH and lPAG, whereas elPBN collateralize to BNST and CEA. This unique feature of lPBN 
anatomy led us to functionally characterize these projections. Using optogenetic approaches, we 
found that VMH- and lPAG-projecting neurons elicited motor sequence reflective of escape-like 
behaviors. Furthermore, we found that lPAG terminal stimulation induces endogenous analgesia, 
likely through descending pathways onto brainstem nuclei and spinal cord. On the other hand, the 
activation of collaterals to BNST and CEA resulted in the formation of aversive memories. We 
wondered how noxious stimulation recruits these different anatomically distinct subdivisions and 
found that a subset of dPBN neurons expressing dynorphin may communicate noxious input 
between different lPBN subregions. Optogenetic activation of PdynCre promoted aversive learning 
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but not escape-like behaviors as observed from terminal stimulations in VMH or lPAG. Moreover, 
genetically ablating PdynCre neurons blocked this effect, demonstrating their critical role in the 
formation of an aversive memory. In summary, our data support the conclusion that collateralizing 
pathways from the lPBN underlie behaviorally distinct aspects of a pain response (Figure 18).  
 
5.1 Limitations of genetic strategies to characterize and manipulate neural activity 
Despite our approach to characterize the anatomical and functional outputs of lPBN in 
richer detail, we realized several shortcomings that need to be factored in when we interpret our 
data. As with all genetic approaches to manipulate neuronal activity, we understand that our 
optogenetic activation of lPBN populations and their outputs do not reflect physiological activity 
of these pathways. Rather, our approach revealed possible behavioral actions these neurons can 
Model: Noxious input is conveyed primarily to the dPBN. Efferents from the dPBN collateralize to VMH and 
lPAG and mediate behavioral responses that enable escape. Dynorphin neurons in the dPBN convey noxious 
information to elPBN. Efferents from the elPBN collateralize onto the CEA and BNST and mediate aversion and 
avoidance memory.  
Figure 18 Model of divergent lPBN circuits 
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initiate, as the neural coding of interoceptive or exteroceptive signals rarely if ever recruit 
homogeneous neuronal populations that fire synchronously during normal physiological states. 
Furthermore, our genetic strategy to ablate a subset of lPBN neurons expressing dynorphin may 
have resulted in plastic changes and neuronal rewiring. Thus, the behavioral responses observed 
may not necessarily reflect the requirement of the ablated neurons. Nevertheless, these modern 
genetic tools provide great advantages to traditional approaches to activate neural populations, 
such as electrical stimulation, or pharmacological/chemical ablation. For example, optogenetics 
and ablation via a genetically-encoded caspase allow for targeted specificity to a particular subset 
of neurons within a heterogeneous population, thereby avoiding off-target effects and passing 
fibers or neighboring neurons.  
An important detail in our optogenetic approach is that all projections were photoactivated 
using the same paradigm – 20 Hz stimulation at a maximal laser power of 10 mW. Using the same 
protocol may help simplify the interpretation of our behavioral data. However, it brings into 
question whether the downstream targets were activated using “ideal” stimulation paradigms. For 
example, VMH neurons downstream of lPBN may respond differently than those downstream in 
CEA (Han et al., 2015a; Wang et al., 2015). Nevertheless, the interrogation of specific projections 
from lPBN to different downstream regions will provide insight into the functional roles of these 
outputs during a nocifensive response. In future studies, I propose to use in vivo calcium imaging 
to determine how different downstream targets respond to varying intensities of noxious 
stimulation. This would allow us to correlate nocifensive behavior with differing grades of calcium 
responses. Subsequently, we can manipulate specific lPBN pathways and determine how such 
perturbations affect both behavior and calcium responses. Together, these experiments would shed 
light on how different intensities of lPBN activity, via physiological responses to noxious stimuli, 
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relate to graded behavioral responses (Browne et al., 2017; Espejo and Mir, 1993; Fan et al., 1995; 
Le Bars, 2002).  
5.2 The lPBN as a coordinator of physiological and behavioral responses to threat 
How do different forms of noxious stimuli recruit lPBN pathways? 
Our data support the idea that divergent lPBN pathways underlie behaviorally distinct 
repertoires that promote either escape-like behavior (dPBN pathway) or aversive memory 
(elPBN). Furthermore, we found that the dynorphin-expressing population may convey noxious 
signals from the environment to engage the different lPBN subnuclei, namely the CGRP-
expressing population in the elPBN. An outstanding question relates to the mechanisms through 
which these circuits are engaged. One possibility is that the lPBN respond to all modalities of 
sensory stimuli, noxious and non-noxious, that either pose a potential threat or causes tissue 
damage, and the intensity of potential damage is correlated with the degree of lPBN activity 
(Campos et al., 2018). Lower intensity stimuli may engage specific subpopulations of lPBN 
neurons, and their degree of activity consequently recruits downstream populations commensurate 
to the level of lPBN activation. Higher intensity stimulation may result in the full behavioral 
expression of a particular circuit – that is, dynamic locomotor actions in addition to the formation 
of an aversive memory. These scenarios describe how lPBN networks may be engaged during 
acute exposure to specific stimuli. 
The response during chronic pain may be more nuanced. A recent study found that chronic 
constriction injury of the infraorbital nerve, a model of neuropathic pain, resulted in 
hyperexcitability of lPBN neurons as measured by increased after-discharges and rebound firing 
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to mechanical and thermal stimulation (Uddin et al., 2018). Whether this resulted from 
neuroplastic changes at the presynaptic terminals, intrinsic properties of lPBN neurons, or from 
brain-wide changes was not investigated. Thus, the hyperexcitability of the lPBN during chronic 
pain may result in the manifestation of a broad range of pathological states that are typically 
comorbid with chronic pain (Nicholson and Verma, 2004; Scioli-Salter et al., 2015). 
What is the functional relevance of collateralizing lPBN efferents? 
In our study we identified collateralizing pathways from lPBN. Although we only studied 
those that exhibited robust axon terminals in downstream targets, we acknowledge that additional 
collaterals likely exist, either from those we identified in this study or separate subpopulations 
collateralizing to other brain regions (Liang et al., 2016a; Tokita et al., 2010). Specifically, we 
found collateralizations to CEA and BNST. Given the reciprocal connectivity with similar brain 
regions and with each other (Lebow and Chen, 2016), what would be the significance of inputs 
into these two areas from the same lPBN population? One possibility is that redundancy in these 
pathways would ensure that ascending input encoding threatening stimuli reach brain areas that 
mediate fear learning. However, these two regions have been implicated to facilitate different 
forms of conditioned learning: the BNST serving a more important role for learning to a diffuse, 
unspecified threat, compared to the CEA, which is thought to underlie conditioning to specific 
cues (Gungor and Pare, 2016; Walker and Davis, 1997; Walker et al., 2009). Whether this is the 
case and is reflected in efferents from lPBN to CEA and BNST remain to be definitively 
confirmed. 
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5.3 Future Directions 
5.3.1  Genetically-defined subpopulations of lPBN and the regulation of autonomic 
functions 
The entire PBN complex comprises at least 12 subnuclei that potentially underlie different 
aspects of coordinating autonomic regulation with behavioral responses. However, the 
contributions of distinct subregions or genetic subsets of lPBN neurons on physiology and 
behavior remain unclear. Experiments critical toward elucidating the contributions of lPBN 
activity with autonomic regulation and behavioral responses would involve improving our 
understanding of functionally distinct lPBN subpopulations. A previous study identified different 
levels of mRNA expression of various neuropeptides that were preferentially expressed within 
certain subregions (Maeda et al., 2009). We and others have identified different Cre-driver mouse 
lines that permit targeting of specific genetically defined lPBN subpopulations (Campos et al., 
2018). Through our viral approach to screen different putative subpopulations, we identified 
several anatomically distinct populations. SstCre and Calb2Cre subsets localize almost exclusively 
in the elPBN, and we found that these neurons project to the same forebrain structures as those 
expressing CGRP, albeit at different intensity levels (data not shown). Tacr1CreER and NtsCre 
neurons were found exclusively within dPBN, and both of these subsets appear to localize in 
different regions and exhibit unique morphology. Although prior studies have implicated CrhCre 
neurons in lPBN (Kainu et al., 1993), our viral tracing approaches revealed primarily neurons 
within the adjacent Kölliker-Fuse, a major contributor of the brainstem respiratory network (Bonis 
et al., 2010; Bonis et al., 2013; Chamberlin and Saper, 1994), and therefore will not be discussed 
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here. Below I outline the anatomical and neurochemical properties of these different lPBN 
subpopulations and speculate on their functional significance in physiology and behavior. 
SstCre  in autonomic regulation 
To our knowledge, the SstCre population in the lPBN has not been characterized in great 
detail. It is likely that this population colocalizes to some degree with the CGRP-expressing 
population as both populations exhibit robust terminal labeling in the CEA. However, we found 
significantly fewer SstCre - expressing axon terminals in the BNST, a forebrain region that also 
receives CGRP-positive lPBN input, and a small number of fibers in the DMH. The CGRP-
expressing population has also been found to be glutamatergic, and most neurons within elPBN 
express Vglut2. These findings suggest that SstCre neurons in lPBN are also excitatory. Although 
the post-synaptic targets of SstCre lPBN neurons remain to be identified, they likely express the 
somatostatin receptor 2 (Sst2) (Dournaud et al., 1996; Schindler et al., 1997). Interestingly, 
somatostatin receptor signaling exerts an inhibitory effect. This raises the peculiar possibility that 
SstCre neurons may be express both the neurotransmitter glutamate in addition to an inhibitory 
neuropeptide. 
The phenomenon that neurons express opposing neuropeptides and neurotransmitters has 
been observed throughout the central nervous system (Tan and Bullock, 2008; van den Pol, 2012). 
The mechanisms through which glutamate and somatostatin release affects circuit activity and 
behavior remain uncertain, though a number of possibilities exist. For example, co-release of 
somatostatin and glutamate may occur locally or at a number of downstream regions, but the 
receptor for somatostatin may not be expressed, resulting in activation of the post-synaptic cells. 
Another possibility may relate to the intensity of SstCre -positive neural activation. At low 
intensities of stimulation, SstCre neurons may release the fast-acting neurotransmitter glutamate, 
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whereas high intensity activation may be required for neuropeptide release. This may be a 
mechanism through which SstCre-expressing neurons in lPBN modulate neural activity, a strategy 
observed in other neural systems (Li and van den Pol, 2006). Lastly, somatostatin may act either 
pre-synaptically for feedback regulation or trans-synaptically to exert a regulatory role via local 
inhibition. 
Within the hindbrain and brainstem somatostatin has been found to exert an inhibitory 
effect on sympathetic outflow. Somatostatin infusion into the rostral ventrolateral medulla (RVM) 
reduces blood pressure and heart rate. It also lowers the respiratory rate via prolongation of 
inspiration and reduction in expiration (Bou Farah et al., 2016; Stengel and Tache, 2017). Whether 
SstCre -expressing lPBN neurons project to RVM, thereby providing the source of somatostatin, 
would be important to understanding how somatostatin signaling in RVM regulates these 
autonomic functions. Furthermore, to what degree these neurons interact with CGRP-positive 
elPBN neurons both locally and their post-synaptic targets in CEA would be important to 
understanding how the different lPBN circuits elicit responses to dangerous stimuli. 
Calb2Cre in pain affect 
lPBN neurons expressing Calb2 have also been found to exhibit projection patterns similar 
to CGRP-expressing and somatostatin-expressing neurons, with the latter two likely being a 
subset. Calb2 encodes a calcium binding protein, but its functional significance within lPBN 
circuitry remains unclear. As Calb2 is expressed in a glutamatergic population, one possibility is 
that it acts as an intracellular Ca2+ buffer to protect against excitotoxicity (Arai et al., 1991). As a 
neurochemically labeled population, Calb2Cre neurons likely also express PACAP and may 
promote anxiogenic and pro-nociceptive states (Neugebauer, 2015). Future studies that manipulate 
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the activity of these neurons would help contribute toward our understanding of their role in 
autonomic regulation. 
Tacr1CreER and cardiovascular control during nociception 
We found that neurons expressing the neurokinin-1 receptor (NK1R) exhibit wide 
branching morphology. Although these neurons do not extend into elPBN, their extensions appear 
to span almost all dPBN subnuclei. The nucleus solitary tract mediates sensory input from arterial 
baroreceptors and chemoreceptors into the same terminal fields as NK1R-expressing dPBN 
neurons (Davern, 2014; Norgren, 1978; Shapiro and Miselis, 1985). This would suggest that 
NK1R-expressing neurons in dPBN may integrate inputs related to autonomic functions with 
behavioral responses (Palmiter, 2018). Consistent with this idea, a number of studies have 
implicated their function in mediating cardiovascular responses to noxious stimulation. 
Intraplantar formalin administration induced reflex tachycardia, elevated heart rate, increased 
mean arterial pressure, and elicited nocifensive licking in rats (Boscan et al., 2005; Culman et al., 
1997). In contrast, repeated noxious mechanical stimulation did not induce Fos expression in 
NK1R-expressing lPBN neurons, suggesting that prolonged noxious input is required for 
activation in this population (Pinto et al., 2003). Infusion of either GABA agonist or NK1R 
antagonist into lPBN attenuated the cardiovascular effects of formalin injection. However, only 
intracerebroventricular injections of NK1R antagonist reduced the nocifensive response. Together, 
these data would argue that NK1R-positive lPBN neurons may be more important in coordinating 
the cardiovascular responses not only to noxious stimuli, but more broadly to situations that may 
induce stress such as intraplantar formalin. The anti-nociceptive effects observed with 
intracerebroventricular injections of NK1R antagonists therefore may be mediated through other 
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brain regions expressing NK1R (Baulmann et al., 2000; Khasabov and Simone, 2013; Khasabov 
et al., 2017).  
NtsCre and antinociception 
Neurotensin is an excitatory neurotransmitter that acts primarily through G protein-coupled 
receptors (Neurotensin receptor 1 and neurotensin receptor 2). We found NtsCre neurons to be 
localized in dPBN, primarily within the ventral aspect within rostral dPBN, consistent with 
previous findings (Block and Hoffman, 1987). However, not much is known about its regulation 
of lPBN activity, whereas its role as a neuromodulator through its receptors NTS1 and NTS2 in 
the central nervous system has been described in different neural systems (Boules et al., 2013; 
Geisler et al., 2006). One group demonstrated that neurotensin injections into lPBN enhanced 
spontaneous activity and vagally-evoked activity (Saleh and Cechetto, 1993). Furthermore, 
sustained vagal stimulation depleted neurotensin within lPBN, suggesting NtsCre neurons respond 
to autonomic changes and release neurotensin to regulate visceral input locally at presynaptic 
terminals or downstream targets (Saleh, 1997). In our preliminary characterization of NtsCre 
neurons, we found dense projections to lPAG, particularly the ventrolateral aspect. It is possible 
that neurotensin release from NtsCre – positive lPBN terminals in the lPAG may underlie 
neurotensin’s anti-nociceptive effects. Microinjections of neurotensin in lPAG resulted in 
glutamate release that acts through both glutamatergic and GABAergic mediators to recruit 
endogenous analgesia via the RVM (Feng et al., 2015; Kleczkowska and Lipkowski, 2013).  
The advancements of mouse genetics and genetic tools to probe circuit function in vivo has 
enabled detailed analysis of how distinct populations of neurons, especially those within a 
heterogeneous mix, contribute to behavioral responses to external stimuli. How the populations of 
neurons detailed above participate in the regulation of autonomic responses, response to 
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nociception, and interactions with more other populations such as the CGRPCre subset would be of 
great interest to improve our understanding of lPBN circuitry.  
5.3.2  Dynorphin and kappa opioid receptor in the lPBN 
We found that optogenetic activation of PdynCre neurons in the lPBN resulted in aversive 
learning but not increased locomotor repertoires indicative of escape-like behavior. Furthermore, 
ablating PdynCre neurons blocked conditioned learning to formalin. The neural mechanism through 
which this occurs remains unclear. It is interesting that nearly all dynorphin-expressing neurons 
also co-express the vesicular glutamate transporter 2 (Vglut2). Dynorphin release acts on its 
cognate receptor kappa opioid receptor (KOR), an inhibitory G protein-coupled receptor. Thus, it 
may be counterintuitive that an inhibitory neuropeptide is co-expressed in glutamatergic neurons. 
Similar to SstCre neurons, which are likely glutamatergic but also express the inhibitory 
neuropeptide somatostatin, the co-expression of opposing neurotransmitters may permit several 
neuromodulatory roles that are dependent on stimulus intensity (van den Pol, 2012). That is, the 
release of dynorphin may only occur following high intensity stimulation or at a specific 
frequency. Regardless, an important factor in determining whether dynorphin signaling occurs 
within local circuits of the lPBN is the presence of KOR. Our lab has generated a Cre-driver mouse 
line in which Cre recombinase has been knocked into the gene for KOR, Oprk1 (Cai et al., 2016). 
In preliminary studies, we stereotaxically delivered Cre-dependent virus encoding a fluorescent 
reporter (eYFP) into the lPBN of Oprk1Cre mice and visualized fluorescently-labeled cells 
throughout the entirety of the lPBN. This was confirmed with FISH to validate that the eYFP-
positive cells co-localized with the Oprk1 probe. With these tools, we can investigate the 
mechanism through which activation of PdynCre neurons recruits local lPBN neurons expressing 
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KOR. A step toward addressing this question would be understanding whether PdynCre neurons 
also express KOR, thereby permitting feedback regulation. Another possibility is that dynorphin 
release acts trans-synaptically through neighboring KOR-expressing neurons via local diffusion. 
Additional experiments are warranted to determine how manipulating these dynorphin- or KOR-
expressing populations affect autonomic regulation and behavioral responses to distinct stimuli, 
such as those that present a potential threat.  
5.3.3  Measuring lPBN-mediated arousal to noxious stimuli 
The role of lPBN activity on mediating arousal has gained growing attention. Several 
groups have begun investigating the functional role of lPBN on reanimation from anesthesia with 
the motive that lPBN signaling may serve critical roles in the arousal system. Chemogenetic 
activation of glutamatergic lPBN neurons decreased emergence time from anesthesia, and this was 
reversed with with chemogenetic inhibition (Luo et al., 2018; Muindi et al., 2016; Wang et al., 
2019). In line with these results, Fos expression was increased in brain regions implicated in sleep-
wakefulness, and these were also downstream of lPBN projections. Furthermore, a recent study 
investigated how different lPBN projections to the preoptic area (POA) or lateral hypothalamus 
(LH) differ in their ability to generate arousal (Qiu et al., 2016). These studies clearly demonstrate 
the involvement of lPBN signaling on the sleep-arousal system. However, the evolutionary 
significance of lPBN activity on the arousal system is underappreciated. In all of our behavioral 
assays, we observed that optogenetic activation of lPBN pathways resulted in significant avoidance 
behavior during the real time place aversion assay. Such behavioral responses would invariably 
require an increased arousal state. The aversive aspect during photoactivation of these pathways 
suggest that increased arousal would enable an animal to respond appropriately to either noxious 
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or potentially dangerous stimuli. Thus, it is likely that these animals behaved in such a way because 
these pathways would also be recruited by exposure to noxious stimuli, thereby promoting 
behavioral and autonomic changes to ensure an animal’s escape from and memory of potentially 
life-threatening stimuli (Kaur et al., 2013; Kaur and Saper, 2019; Kaur et al., 2017; Palmiter, 2018; 
Saper, 2016). Although our study did not measure changes in cortical activity, as measured by 
electroencephalogram (EEG), we hypothesize that the activation of lPBN outputs to the 
downstream regions in our study would promote brain-wide changes to favor a wakeful state as a 
result of exposure to potentially harmful stimuli. One possible way to test this would involve the 
use of Cre-mediated targeting of neural populations expressing Fos in response to noxious 
stimulation (Rodriguez et al., 2017; Sakurai et al., 2016).  
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Appendix Introduction 
The Appendix comprises a compilation of other major projects and experiments that I have 
worked on throughout my graduate studies in Dr. Sarah Ross’s lab. Appendix A features 
experiments to reveal the contributions of kappa opioid receptor signaling on primary afferents in 
neurogenic inflammation. Experiments were performed in the Ross lab. Appendix B highlights 
behavioral experiments that aim to determine whether Nogo receptor signaling mediates the in 
vivo effects of Aβ pathology on learning. These experiments were performed with Dr. Zachary 
Wills. Appendix C and D are clinical projects done with the Department of Neurosurgery. The 
first characterizes the effectiveness of fixed-pressure shunts for hydrocephalus in an adult cohort. 
The second is a case report on a pediatric patient with the rare diagnosis of Schimmelpenning 
syndrome. Additional projections that I have contributed can be found in the following PubMed 
link: https://www.ncbi.nlm.nih.gov/myncbi/1rKQBuyLmspky/bibliography/public/ 
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Appendix A Kappa opioid receptor signaling inhibits neurogenic inflammation 
Primary afferents are known to be inhibited by kappa opioid receptor (KOR) signaling. 
How KOR signaling contributes to neurogenic inflammation remains unclear. Based on the finding 
that KOR is expressed in mouse and human peptidergic afferents, we sought to address whether 
KOR activation could inhibit neurogenic inflammation. To address this question, we measured 
plasma extravasation in mice that had received an intraplantar injection of capsaicin in the presence 
or absence of a KOR agonist (Figure 19A). For these experiments, we compared the effects of 
nalfurafine, a centrally penetrating KOR agonist (Endoh et al., 2001; Nagase et al., 1998), to those 
of either ICI204,488 or FE200665 (Vanderah, 2010), two peripherally restricted KOR agonists 
that have extremely limited ability to cross the blood-brain barrier (Shaw et al., 1989; Vanderah, 
2010). In control mice, treatment with the TRPV1 agonist capsaicin resulted in a significant 
increase in Evans blue in the ipsilateral paw relative to the contralateral paw. In contrast, treatment 
with any of the three KOR agonists significantly reduced capsaicin-induced plasma extravasation 
(Figures 19B and 19C). These observations are consistent with previous data (Green and Levine, 
1992). Similar results were observed when neurogenic inflammation was induced with an 
inflammatory mixture of bradykinin and prostaglandin E2 (Figure 20). Importantly, we found that 
nalfurafine failed to attenuate Evans blue extravasation in KOR-/- mice, confirming that the 
inhibition of neurogenic inflammation by nalfurafine is specific to KOR (Figure 19D). Finally, as 
an independent measure of neurogenic inflammation, we also assessed the effects of KOR agonists 
on the increase in paw temperature observed following capsaicin-injection into the hindpaw. 
Intraplantar injection of capsaicin in vehicle-treated mice resulted in an increase in paw 
temperature that was significantly attenuated in mice treated with either nalfurafine or ICI204,488 
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(Figures 19E and 19F). Together, these results suggest that activation of KOR in the periphery is 
sufficient to inhibit neurogenic inflammation. 
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(A) Schematic illustrating experimental design to measure the effect of KOR agonists on plasma extravasation induced 
by capsaicin. (B and C) Representative images (B) and quantification (C) of Evans blue extravasation upon injection 
of capsaicin (0.1%) into the ipsilateral paw of mice pretreated with vehicle (Control), nalfurafine (20 mg/kg), 
ICI204,448 (10 mg/kg), or FE200665 (12 mg/kg), as indicated. Data are presented as mean ± SEM, and symbols 
represent data points from individual animals (two-way ANOVA followed by Tukey’s post hoc test; *p < 0.05; n = 
4–6 mice/condition). (D) Capsaicin-induced Evans blue extravasation in KOR-/- mice treated with vehicle (Con) or 
nalfurafine (Nalf, 20 mg/kg). Data are represented as mean + SEM, and symbols represent data points from individual 
animals (two-way ANOVA; NS p > 0.05; n = 3 mice/condition) (E and F) Representative images (E) and quantification 
(F) of infrared thermography to assess paw temperature. Injection of capsaicin (0.1%) caused a transient increase in 
the temperature of the ipsilateral paw of mice pretreated with vehicle (Control), which was significantly greater than 
that observe in mice pretreated with nalfurafine (20 mg/kg) or ICI204,448 (10 mg/kg), as indicated. Data represent 
mean ± SEM (two-way ANOVA followed by Holm-Sidak multiple comparison test; * or # indicates p < 0.05 between 
nalfurafine and vehicle or ICI and vehicle groups, respectively; n = 4–5 mice/condition). 
Figure 19 Peripherally Selective KOR Agonists Inhibit Neurogenic Inflammation and Sensitization of 
Nociceptive Afferents. 
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Figure 20 KOR agonists inhibit neurogenic inflammation induced by bradykinin and prostaglandin E2.  
Evans blue extravasation upon injection of bradykinin:prostaglandin E2 (10 μM:10 μM, 10μL) into the ipsilateral 
paw of mice pretreated with vehicle (Con), nalfurafine (Nalf, 20 μg/kg), ICI204,448 (ICI, 10 mg/kg), or 
FE200665 (FE, 12 mg/kg), as indicated. Data are mean ± SEM and symbols represent data points from individual 
animals (two-way ANOVA followed by Tukey’s post hoc test; ** p < 0.01; *** p < 0.001, n = 4 – 5 
mice/condition). 
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Appendix B ADDLs Block Learning via NgR-Mediated Inhibition of Spine Assembly and 
T-Type Channels 
An important measure of Aβ pathology is its impact on learning. To determine the role of 
NgRs in Aβ-mediated inhibition of learning, we introduced ADDLs (∼10 pmols) via a single 
intracerebroventricular (ICV) injection into the mouse brain (Figures 21A and 22A) and examined 
its impact on novel object recognition (NOR) learning. Consistent with previous work (Figueiredo 
et al., 2013), ADDLs block NOR learning 7 days after ICV injection in comparison to control 
(DMSO)-injected animals (Figure 21B and Figure 22B). In contrast, NgR family knockouts 
(NgRNNN) are unaffected by ADDLs, showing normal NOR behavior (right panel). Note that 
none of the ICV-injected animals show deficits in movement (open field analysis; Figure 22C). 
These findings suggest NgRs mediate Aβ’s inhibition of learning.  
  
 99 
(A) Timeline of ICV injections, NOR behavioral analysis, acute slice recordings, and dendritic spine analysis. (B) 
ADDL-mediated deficits in novel object learning rescued by NgR family loss. Top: illustration of NOR sample and 
choice test with familiar (Fam) and novel (Nov) objections assessing 2-hr retention memory. Bottom: quantification 
of exploration time with indicated objects following ICV injections with DMSO (0.8 μL of 2% DMSO) or ADDLs 
(0.8 μL of 50 μM Aβ monomer equivalent). n = animals indicated by circles. Bars represent means; error bars SEM. 
∗p < 0.05 versus fixed 50% (chance), Student’s t test. 
  
Figure 21 ADDLs Block NOR Learning by NgR Family-Mediated Inhibition of Spine Assembly and T-Type 
Currents 
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(A) (Left) Mouse atlas indicating stereotactic location of ICV injections. (Right) Mouse brain section 2 hours 
following test injection with blue dye illustrating injection site and spread of dye to right and left ventricles (blue 
arrows). (Below) Immunostained mouse brain section 24 hours following biotin-LC-ADDL ICV injection. Hatched 
boxes (numbered) are expanded on the right highlighting (white arrows) the biotin-LC-ADDL labeling of the central 
(2) and right ventricles (3). Note the absence of staining in left ventricle (1). Scale bar = 100μm. (B) Novel object 
recognition analysis at indicated times (24 hours or 7 days) following ICV injection of control animals (8-week-old 
C57B6 males). Quantification of the mean exploration time with indicated objects (familiar or novel) and indicated 
conditions (2% DMSO or ADDLs ICV). Error bars equal SEM. (n) indicated by circles (each representing an animal) 
in graph. * p<0.01 **p<0.05 vs 50% (chance) Student’s t test. (C) Quantification of the mean total distance travelled 
in open field analysis for indicated animals (NgR genotypes) and conditions (2% DMSO or ADDLs ICV). Error bars 
equal SEM. n = 8 - 13 mice per group. 
  
Figure 22 Extended Analysis of ICV Injections of ADDLs 
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Appendix C Exclusive use of fixed pressure valves for cerebrospinal fluid diversion in a 
modern adult cohort. 
C.1 Introduction 
The introduction of ventriculoperitoneal shunt insertion transformed the treatment of 
hydrocephalus and continues to be the most frequently used method of hydrocephalus management 
in both pediatric and adult patient populations (Patwardhan and Nanda, 2005; Weisenberg et al., 
2016). Gradually, fixed pressure valve systems have lost ground against newer programmable 
valve systems as the favored device of choice for shunt insertion. Such enhancements have been 
purported to provide reductions in risks for shunt malfunction and improved dynamic management 
of intracranial pressure (Hanlo et al., 2003; Mpakopoulou et al., 2012; Stein and Guo, 2008). 
Despite this, the rates of complication and shunt revision persist and contribute to the cost of 
treatment (Merkler et al., 2017; Patwardhan and Nanda, 2005; Simon et al., 2008; Stein and Guo, 
2008; Stone et al., 2013). Thus, no clear consensus exists for the use of programmable over that of 
nonprogrammable shunts (Hatlen et al., 2012; Ringel et al., 2005; Stone et al., 2013; Xu et al., 
2013). 
Much of the published literature comparing the costs and clinical outcomes of 
programmable versus nonprogrammable shunt insertions focuses on shunt use in the pediatric 
hydrocephalus population (Lam et al., 2014; Pollack et al., 1999; Simon et al., 2008). Furthermore, 
few longitudinal studies have evaluated the management of hydrocephalus in adult patients with 
fixed shunts in a modern cohort (Khan et al., 2015; Korinek et al., 2011; Reddy et al., 2012, 2014; 
Reddy et al., 2011). Here, we investigated in detail the characteristics and outcomes of an adult 
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patient population who universally received fixed valve shunt insertion as the initial treatment of 
hydrocephalus by a single physician. 
C.2 Materials and Methods 
Data collection 
We retrospectively examined clinical records within our institution from January 2000 
through March 2017 of all adult patients who underwent fixed shunt placement by a single 
physician, Daniel Wecht (DW) for treatment of hydrocephalus at the University of Pittsburgh 
Medical Center. All patients received peritoneal-based catheters during their initial shunt 
placement. Patients that had received shunts previously by other providers were not included. 
Indications for shunt placement were categorized as follows: hemorrhage, normal pressure 
hydrocephalus (NPH), pseudotumor cerebri, tumor, and infection. The small number of patients 
whose etiology of hydrocephalus did not fit the above categories were grouped as others and 
comprise the following: traumatic brain injury, ischemic stroke, and hydrocephalus of unknown 
etiology. 
 
Definitions 
Patients who received shunt insertion for hydrocephalus were identified using current 
procedural code (CPT) 62223 as well as an electronic medical record query for the term (shunt) 
among patients who had been seen by the senior author. The category “hemorrhage” comprised 
any non-traumatic intracranial hemorrhage including subarachnoid, intraventricular, and 
intraparenchymal hemorrhages. Shunt revisions were defined as reoperation on a previously 
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implanted shunt for any indication. Mechanical failure of the shunt was determined during 
reoperations for shunt revisions by selectively cannulating the valve and the tubing distal to the 
valve and assessing for the presence of drainage and normal flow using a barometer filled to 35 
mm H20. The proximal catheter was observed after removal of the shunt valve to determine 
proximal obstruction. The shunt was removed and assessed for any obstruction or inability to drain 
properly proximally, distally, or at the valve. Any shunt that fulfilled either criteria was considered 
a malfunction due to mechanical failure. Overdrainage and underdrainage were determined by 
radiographic findings combined with clinical symptoms, such as positional headache, and the 
absence of any mechanical problem with the proximal shunt, distal shunt, or the valve itself during 
intraoperative inspection. 
Patients with pseudotumor or NPH diagnoses were selected based on clinical improvement 
of relevant symptoms after high volume lumbar puncture or three-day lumbar drain trial. In the 
case of pseudotumor cerebri, the presence documented, progressive vision loss was also an 
indication. Patient with hemorrhage and other forms of acute hydrocephalus typically underwent 
prior placement of an external ventricular drain, with a gradual attempt at weaning the drain via 
incremental increases in the pressure level followed by a 24–48 hour clamp trial, being attempted. 
Patients unable to be weaned from external cerebrospinal fluid drainage had shunts placed. 
 
Analysis 
Statistical analysis was performed with GraphPad Prism 7.0 and IBM SPSS version 25. 
Chi-squared and Fisher's exact test was performed on categorical data. Mann-Whitney tests were 
used for continuous variables between two groups. Kaplan-Meier curves were performed on 
survival data and comparisons were made using the log-rank (Mantel-Cox) test. Comparisons 
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among three or more groups were made using Kruskal-Wallis test followed by Dunn's post-hoc 
test. The level of significance was p < 0.05. 
C.3 Results 
We collected data from 169 patients who had undergone insertion of fixed shunts between 
2000 and 2017 for the treatment of hydrocephalus. We excluded 43 patients who had been 
previously shunted, resulting in 126 patients shunted by a single physician. One hundred twenty-
three of 126 (97.6%) of patients received parietal ventriculoperitoneal (VP) shunting. Occipital 
and frontal shunting were performed in 2 (1.6%) and 1 (0.8%) of initial operations, respectively. 
One hundred twenty-three of 126 (97.6%) operations used Pudenz valves. One operation involved 
insertion of a Delta valve and the remaining two patients received Heyer-Schulte valves. The 
majority of valve pressures were set at medium (118 of 125, 94.4%). Seven of 125 were set at low 
(5.6%). These patients were subsequently categorized into etiologies for hydrocephalus: 
hemorrhagic, NPH, tumor, pseudotumor cerebri, infection, and others (see below). Of the patients 
with low valve pressure settings, 4 of 7 (57.1%) fell into the hemorrhagic group, 2 of 7 (28.6%) 
had tumors, and 1 of 7 (14.3%) had an infection. 
The distribution of patients across hydrocephalus etiologies is as follows: hemorrhagic (54 
of 126, 42.9%), NPH (48 of 126, 38.1%), tumor (8 of 126, 6.3%), pseudotumor cerebri (7 of 126, 
5.6%), infection (1 of 126, 0.8%), and others (8 of 126, 6.3%) (Table 1). Forty-eight (38%) patients 
were male whereas 78 (62%) were female. Further details of the distribution of male and female 
patients across etiologies of hydrocephalus can be found in Table 2. When categorized by etiology, 
we found the following mean ages of male and female patients respectively: 58.4 ± 6.1 vs. 56.8 ± 
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4.7 years (hemorrhagic), 74.9 ± 3.8 vs. 71.3 ± 3.3 years (NPH), 59.8 ± 15.3 vs. 71.7 ± 23.2 years 
(tumor), and 52.7 ± 15 vs. 58.4 ± 8 years (other). Only females exhibited pseudotumor cerebri at 
a mean age of 31 ± 5.1 years. A single female patient with infectious etiology was 75 years old. 
 
Curved bracketed values indicate proportion of total. Follow up 
time is indicated in months as mean ± standard error. 
 
No differences in proportion of shunt failures were found between males and females 
(Fisher's exact test, p = 0.5467). However, when stratified by etiology the proportion of shunt 
revisions was greater in female than in male patients with NPH (p = 0.0158, Table 2). Mean follow 
up time for all patients was 28.1 ± 6.1 months (Table 1). By etiology, the follow up times are listed: 
22.5 ± 5.2 months (hemorrhagic), 28.1 ± 7.1 months (NPH), 7.1 ± 4.7 months (pseudotumorerebri), 
65.9 ± 64.5 months (tumor), and 43.6 ± 17.4 months (other). A single patient with infectious 
etiology followed up in 1.7 months. 
Table 2 Distribution of patients receiving fixed valve shunts 
and shunt revisions. 
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Shunt revision 
Thirty three of 126 patients (26.2%) required at least one shunt revision (Table 3), with 
mechanical shunt malfunction (13 of 33, 39.4% of failures) being the most common reason for 
failure. Six of 13 malfunctions resulted from mechanical failure at the valve, 2 of 13 occurred 
proximally, and 5 of 13 occurred distally. Shunt infection was the second most common reason 
for shunt revisions (7 of 33, 21.2% of failures, 5.6% of all patients). Of note, antibiotic impregnated 
catheters are not routinely used at our institution in adults. Shunts migration occurred in 6 of 33 
(18.2% of failures) of patients. Misplaced shunts accounted for three of 33 (9.1% of failures) of 
shunt revisions. Both overdrainage and underdrainage each resulted in 2 (6.1% of failures) shunt 
revisions, and all 4 patients whose shunts failed for this reason had NPH. Importantly, all shunts 
were functional in patients experiencing overdrainage and underdrainage. 
 
 
Table 3 Distribution of shunt revisions across genders and 
etiology of hydrocephalus. 
NA indicates not applicable. 
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When stratified by etiology of hydrocephalus compared to number of patients requiring at 
least one revision, a large percentage of patients (14 of 33, 42.4% of failures) whose shunts 
required revision developed hydrocephalus initially as a result of hemorrhage. A similar proportion 
was found in patients who required treatment for NPH (13 of 33, 39.4% of failures). Two patients 
(6.1% of failures) with pseudotumor cerebri required treatment shunt failure, while no shunts failed 
in patients treated for hydrocephalus due to tumor or infection. Four patients (12.1%) whose 
etiology of hydrocephalus did not fall in the above categories required shunt revision (Table 1). 
When considering shunt revisions as a fraction of the total number of shunt placements by 
etiology, shunt revisions occurred in similar proportions among those with hemorrhage (14 of 54, 
25.9%), NPH (13 of 48, 27.1%), and pseudotumor cerebri (2 of 7, 28.6%). Two of 4 (50%) patients 
categorized as “others” required shunt revision. Zero patients in either “infection” or “tumor” 
groups required revision (p = 0.165). Furthermore, the rate of revisions between the hemorrhage 
and NPH groups that received fixed shunts were not different (p = 0.873, Fig. 1). 
 
Table 4 Distribution of number of shunt revisions. 
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Nineteen of 33 patients (57.6%) required a single revision. Ten of 33 patients (30.3%) required 
two shunt revisions during follow up. Four of 33 patients (12.1%) required three or more revisions. 
Together, shunt revisions occurred at an average rate of 1.7 ± 0.2 per patient among those requiring 
at least one revision. 
 
Presenting symptoms 
Of 126 patients who received insertion of fixed VP shunt, we were able to characterize the 
preoperative symptomology of 109 patients: 41 from hemorrhagic, 46 from NPH, 1 from infection, 
8 from other, 7 from pseudotumor cerebri, and 8 from tumor. Across all etiologies, 69 of 109 
patients (63.3%) exhibited decreased cognitive deterioration, 61 (56%) presented with gait 
disturbances, 34 (31.2%) presented with urinary incontinence, and 31 (28.4%) presented with 
headaches. A smaller number of patients presented with the following symptoms: decreased 
wakefulness (17 of 109, 15.6%); nausea and/or vomiting (11 of 109, 10.1%); vertigo (5 of 109, 
4.6%), blurry vision (8 of 109, (7.3%), or papilledema (6 of 109, 5.5%). No patients presented pre-
operatively with double vision. By etiology, the most common symptoms presented within the 
Figure 23 Survival curve of shunts.  
(Left) All patients (Right) Hemorraghic and NPH groups. Log-rank test was performed. 
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hemorrhagic group were headaches (23 of 41, 56%) and cognitive decline (22 of 41, 53.7%). The 
most common symptoms within the pseudotumor cerebri group were headaches (4 of 7, 57.1%), 
blurry vision (7 of 7, 100%), and papilledema (6 of 7, 85.7%). The majority of patients within the 
tumor group presented with cognitive decline (6 of 8, 75%) and gait instability (3 of 8, 37.5%) 
(Table 4). 
 
Table 5 Summary of presenting symptoms by etiology. 
Values indicate number of patients with symptoms. Parentheses 
indicate the percent of patients within categories. 
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Post-operative symptom effect 
We found that 47 of 126 (37.3%) patients passed away at the time the data was collected. 
No deaths were associated with the peri- or post-operative surgical complications. Of those 
patients the mean survival length from the time of shunt insertion until mortality date was 50.3 ± 
6.5 months. 
We next characterized the resolution of symptomology patient by patient following shunt 
insertion and found 74 patients who met criteria to compare their pre-operative and post-operative 
symptomology: 23 from hemorrhage, 33 from NPH, 1 from infection, 5 from other, 6 from 
pseudotumor cerebri, and 6 from tumor. Fixed shunt insertion was found to resolve headaches in 
13 of 17 patients (76.5%), blurry vision in 5 of 6 patients (83.3%), papilledema in 5 of 6 patients 
(83.3%), cognitive decline in 39 of 43 patients (90.7%), decreased wakefulness in 8 of 9 patients 
(88.9%), gait instability in 35 of 43 patients (81.4%), urinary incontinence in 19 of 22 patients  
86.4%), nausea/vomiting in 3 of 4 patients (75%), and vertigo in 2 of 3 patients (66.7%). Further 
details regarding the resolution of symptoms by etiology are found in Table 5. 
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Table 6 Summary of resolved symptoms following shunt insertion 
by patient. 
Parentheses indicate the percent of resolved symptoms within each 
category. 
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C.4 Discussion 
Although hydrocephalus arises from diverse etiologies, VP shunt insertion continues to be 
the most frequently used treatment in both the pediatric and adult patient populations (Merkler et 
al., 2017; Stein and Guo, 2008; Wu et al., 2007). Despite significant technological advancements 
and constructions of ventriculoperitoneal shunts, the rates of complication following shunt 
insertion remain considerable and contribute to the excessive cost of treatment (Hanlo et al., 2003; 
Hoshide et al., 2017; Kestle et al., 2005; Lifshutz and Johnson, 2001). Here, we detailed the use 
of fixed shunts in 126 patients from 2000 – 2017 from a single physician. A major concern for the 
use of fixed shunts is the complication of overdrainage or underdrainage of cerebrospinal fluid 
(CSF) (Xu et al., 2013). We found that 26.2% of patients with a fixed shunt required at least one 
revision, and the most common cause of shunt revision was due to malfunction, making up 39.4% 
of failures. This is consistent with previous studies (Borgbjerg et al., 1995; Di Rocco et al., 1994; 
Kaestner et al., 2017; Wu et al., 2007). 
Etiology of hydrocephalus has also been found to be correlated with frequency of shunt 
revisions. In our study, patients in either hemorrhage or NPH categories accounted for the majority 
of shunt revisions (42.4% and 39.4%, respectively). However, the proportion of shunt failures were 
similar in either groups (25.9% and 27.1%, respectively). This may be explained by the differences 
in number of patients in each of our categories. Nevertheless, the low proportion of failures in 
those shunted for NPH is comparable to those found in previous studies (Kaestner et al., 2017; 
McGirt et al., 2005). Overdrainage and underdrainage reflected only 6.1% of failures, respectively 
(2 of 33). Interestingly, all four patients suffering from symptoms due to overdrainage or 
underdrainage had an initial diagnosis of NPH. Those with symptoms of underdrainage were 
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revised to a low pressure fixed valve with no further complications, whereas the two patients with 
overdrainage issues subsequently received a Strata valve set to 2.5 and Delta valve set to 2.5. 
Shunt insertion was found to resolve a large proportion of presenting symptoms. Nearly all 
patients with hemorrhagic hydrocephalus experienced headache resolution as well as 
improvements in cognitive decline and decreased wakefulness. Patients with NPH primarily 
presented with cognitive decline, gait instability and urinary incontinence that were also resolved. 
Hydrocephalus due to pseudotumor cerebri caused primarily headaches, blurry vision, and 
papilledema. Shunt insertion resolved these symptoms in the majority of patients. 
A major concern for the use of programmable shunts is its significant cost compared to that 
of fixed shunts. At our institution, the total shunt supply implant cost and direct supply expenses 
for programmable shunts were more expensive than using fixed valves (Agarwal et al., 2018). The 
lack of consensus over the cost-benefit of using a more expensive programmable valve has 
generally been mixed. 
C.5 Limitations 
Several limitations of our study may have biased our results. Our study retrospectively 
reviews the data of patients receiving fixed shunts. We therefore cannot randomize prospectively 
matched groups, subjecting our analysis to potential confounding bias. Furthermore, data was 
collected from a single institution that predisposes our study to selection bias based upon the 
demographics at this institution. 
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C.6 Conclusion 
Our study characterizes the clinical outcomes of a modern cohort of adult patients receiving 
fixed shunts by a single physician at our institution for the treatment of hydrocephalus due to 
diverse etiologies. We further compare the clinical outcomes for patients receiving fixed shunts to 
those that of programmable shunts. From the patient population evaluated in this study, 
hydrocephalus occurred most frequently as a result of NPH or hemorrhage, and the revision rates 
were similar between these two groups. Shunt malfunction was found to be the primary reason for 
failure. The proportion of failed shunts remains considerable and comparable to those in decades 
past. Given the experience of the physician performing these shunt insertions, our study highlights 
the need for improvements in the design of fixed shunt valve designs to reduce failures resulting 
from malfunction. 
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Appendix D Is Schimmelpenning syndrome associated with intracranial tumors? A case 
report. 
D.1 Introduction 
Schimmelpenning syndrome, or linear sebaceous nevus syndrome (OMIM 163200) is a 
rare, well-defined constellation of clinical phenotypes associated with the presence of nevus 
sebaceous. It classically presents with well-defined yellow-orange plaques located on the scalp 
or neck and cerebral, ocular, and skeletal defects (Happle, 2010). Through various DNA 
sequencing techniques, a number of groups have consistently and independently identified the 
same mutation in the HRAS or KRAS genes as the primary mechanism responsible for the 
majority of the clinical manifestations. Mutations in pro-oncogenic signaling pathways increase 
the likelihood of nevus sebaceous to develop malignant potential, and up to 24% of these patients 
develop secondary cutaneous neoplasms (Moody et al., 2012). However, extracutaneous 
neoplasms associated with the central nervous system have rarely been reported in 
Schimmelpenning syndrome patients (Baker et al., 1987). We report a rarely described case of a 
child with a diagnosis of Schimmelpenning syndrome and a central nervous system tumor in this 
case a pilocytic astrocytoma (PA). 
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D.2 Radiographical findings 
A 15-year-old male patient diagnosed with Schimmelpenning syndrome as a neonate 
presented to the Children’s Hospital of Pittsburgh after a generalized tonic-clonic seizure. An 
electroencephalogram detected focal epileptiform discharges in the left hemisphere. A head 
computed tomography scan revealed multiple calcified abnormalities, largely within the left 
temporal lobe (Fig. 24). A magnetic resonance imaging (MRI) scan of the brain identified a 
heterogeneously enhancing expansile lesion with cystic components measuring 3.3 × 1.8 × 2.3 
cm centered in the left temporal stem. Two additional expansile lesions were identified, one 
adjacent to the left foramen of Monro and the other adjacent to the choroid plexus in the atrium 
of the left lateral ventricle, measuring 1.6 × 1 × 0.8 cm and 2.5 × 1.3 × 1.3 cm, respectively 
(Fig. 25). No midline shift was seen. An MRI of the spine was negative. Of note, the patient had 
a non-contrast brain MRI during infancy for unrelated reasons which did not demonstrate an 
obvious lesion.  
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Figure 24 Preoperative transverse computed tomography 
image indicating a calcified lesion abutting the temporal horn 
Operative Course  
Following a frontotemporal craniotomy and dural opening, a temporal corticectomy was 
made and the ventricle was entered. The tissue of the medial ventricular wall was soft, grayish, 
and abnormal. When the tumor had been largely debulked by both visual inspection and 
neuronavigation, resection was terminated. Total resection was not attempted given the presence 
of the metastatic lesions and adjacent critical structures. Molecular analysis revealed no 
abnormalities in the proto-oncogenes BRAF, HRAS, or KRAS. Histopathological analysis 
confirmed the sampled tissue to be a WHO grade 1 PA. The case was reviewed in a 
neuropathological consensus conference with complete agreement on the diagnosis. The patient 
recovered with no neurological deficits and was discharged on postoperative day 5. The patient 
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has been closely followed with serial MRIs, and at the time of this report, 6 months after surgery, 
no evidence of tumor progression has been noted. Chemotherapy will be administered only for 
progression. 
 
Preoperative T1 images with contrast (a), FLAIR (b), and T2 (c) MRI sequences 
demonstrating a heterogeneously enhancing, cystic mass of the temporal stem abutting 
the hippocampus and temporal horn of the lateral ventricle with no significant edema 
Figure 25 Radiographic images of intracranial mass. 
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and minimal mass effect on adjacent structures. (d) FLAIR sequence depicting left 
foramen of Monro and left atrial satellite lesions. 
 
Table 7 Summary of intracranial lesions associated with Schimmelpenning syndrome and associated 
disorders 
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D.3 Discussion 
This report concerns a patient with a clinical diagnosis of Schimmelpenning syndrome who 
presented with a seizure secondary to a low-grade astrocytoma. Compelling data indicates that 
nearly all tissue samples from lesions of Schimmelpenning syndrome patients, but not from normal 
adjacent tissue of the same individual due to the mosaic nature of the condition, exhibit mutations 
in either HRAS or KRAS. Most predominantly, the hotspot mutation in HRAS c.37G>C causes a 
p.G13R substitution that constitutively activates the Ras/Raf/ MAPK signaling pathway (Groesser 
et al., 2012), supporting the conclusion that Schimmelpenning syndrome arises from genetic 
mosaicism resulting in an autosomal dominant RASopathy (Happle, 2013). Schimmelpenning 
syndrome patients most commonly present with skeletal, neurological, and ocular extracutaneous 
features. Neurological abnormalities have been previously reported to occur in the majority of 
cases, although one study found neurological deficits in only 14 of 196 cases (7%) (Baker et al., 
1987; van de Warrenburg et al., 1998). Major neurological features include mental retardation, 
seizures, and structural cerebral deformities such as hemimegalencephaly. The full clinical 
phenotype of these neurological features may gradually develop over time. In our patient, no 
records indicated neurological involvement at birth. Furthermore, neurological examination 
revealed no remarkable abnormalities other than the presenting new onset generalized seizures 
caused by the PA. Ophthalmologic abnormalities have also been commonly reported in individuals 
with Schimmelpenning syndrome (Diven et al., 1987). These ocular features frequently manifest 
as lipodermoids, choristomas, and colobomas. We observed in our patient a unilateral corneal 
dermoid cyst resulting in severe anisometropic amblyopia.  
Neurological symptoms occur fairly commonly in patients with Schimmelpenning 
syndrome. However, as noted above, the full clinical presentation of neurological symptoms may 
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only develop as affected patients age because physiological abnormalities resulting from 
anatomical deformities, such as maldeveloped cranial nerves and neurovascular defects, develop 
over time. Furthermore, the growth of cerebral neoplasms may contribute to the constellation of 
neurological symptoms, including increased intracranial pressure, head circumference 
enlargement, and seizures. Additional studies investigating intracranial tumor involvement and the 
manifestation of neurological symptoms are warranted. Nevertheless, the rare incidence of 
extracutaneous neoplasms involving the central nervous system and gradual development of 
neurological symptoms would argue for careful monitoring for the sudden onset of any 
neurological symptoms (Happle, 2010). Genetic testing should be performed on affected tissues 
evaluating for mutations in genes affecting the Ras/Raf/MAPK signaling pathways.  
Sporadic PAs have been found to arise primarily through chromosomal 7q34 duplication 
generating a novel fusion protein comprising the KIAA1549 locus and BRAF kinase domain (Bar 
et al., 2008; Jacob et al., 2009). Despite their generally indo lent nature, PAs have been associated 
with neurofibromatosis type 1 (NF1), with approximately 15% of NF1 patients developing PA 
(Listernick et al., 2007). The NF1 gene encodes the GTPase-activating protein neurofibromin, 
which acts as a negative regulator of RAS. Mutations in neurofibromin result in the autosomal 
dominant phenotype of NF1, driven by increased activity of RAS and the downstream MAPK and 
mechanistic target of rapamycin (mTOR) signaling pathways (Helfferich et al., 2016). 
Interestingly, optic pathway gliomas in NF1 patients have been found to progress more slowly 
compared to sporadic tumors (Helfferich et al., 2016; Koeller and Rushing, 2004). 
In contrast, the occurrence of extracutaneous neoplasms affecting the central nervous 
system, most of which appear benign, have rarely been observed in Schimmelpenning syndrome 
patients. In one report a patient presenting with nevus unius lateralis was found to have a grade 1 
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astrocytoma in the right anteromedial temporal lobe, possibly originating from the hypothalamus 
(Meyerson, 1967). A second case reported a mixed glioma originating from the left parietal region 
(Alfonso et al., 1987). Optic gliomas have been observed in a handful of Schimmelpenning 
syndrome patients. Similar to those found in NF1 patients, optic gliomas were detected in children 
and were of an indolent nature (Sato et al., 1994; Seifert et al., 2012). Whereas preclinical studies 
using genetic mice to alter the expression of neurofibromin have found preferential development 
of optic gliomas compared to other NF1-associated tumors (Listernick et al., 2007), no such studies 
have been performed to determine the relationship between Schimmelpenning syndrome and the 
development of any intracranial tumors. However, the close relationship between these two 
conditions, the occurrence of PAs, and the Ras signaling pathway suggest involvement of a 
common pathway in their pathogenesis. 
Cerebral hamartomas have also been found in Schimmelpenning syndrome patients, 
although this occurs infrequently as well (Clancy et al., 1985). Benign congenital tumors such as 
choristomas and hemangiomas have been reported in Schimmelpenning syndrome patients. 
Choristomas have typically been reported affecting the epibulbar region and demonstrate several 
histological features (Alfonso et al., 1987). Complex choristomas typically contain ectodermal and 
mesodermal tissues such as cartilage and bone (Pe'er and Ilsar, 1995). Lipomas have been reported 
in patients with encephalocraniocutaneous lipomatosis (ECCL), which symptomatically appears 
similar to those with Schimmelpenning syndrome. These include cerebral malformations and 
cutaneous and ocular anomalies, including choristomas. However, a benign lipoma of the scalp 
underlying regions of alopecia, known as nevus psiloliparus, occurs uniquely with ECCL. The 
presence of benign lipomas elsewhere in the central nervous system also occurs frequently in 
ECCL patients (Moog et al., 2007). The location of these benign neoplasms affecting the nervous 
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system strongly suggests that these tumors arise from RASopathy within either the ectoderm or 
neuroectoderm during development. Although small benign masses within the central nervous 
system may pose a limited risk, the possibility of potential growth should be of concern as their 
enlargement may cause a mass effect resulting in the compression of neighboring structures and 
consequent development of neurological abnormalities. A summary of Schimmelpenning 
syndrome and related disorders with intracranial masses is documented in Table 1 (Barth et al., 
1977; Booth and Rollins, 2002; Brodsky et al., 1997; Canyigit and Oguz, 2006; Chandravanshi, 
2014; Choi and Kudo, 1981; Grimalt et al., 1993; Kamate et al., 2009; Levin et al., 1984; Lin and 
Yan, 2010; Mall et al., 2000; Meyerson, 1967; Mollica et al., 1974; Moskowitz and Honig, 1982; 
Okumura et al., 2012; Park et al., 2009; Rizzo and Pavone, 2015; Sato et al., 1994; Seawright et 
al., 1996; Seifert et al., 2012; Sharma et al., 2012; Shields et al., 2014; Watanabe et al., 2016; Yan 
et al., 2007). 
In a recently reported case, an infant presented with multisystem involvement similar to 
that of Schimmelpenning syndrome and an anaplastic astrocytoma resulting from a BRAF V600E 
mutation, but no mutations HRAS or KRAS (Watanabe et al., 2016). These rare cases suggest the 
possibility that Schimmelpenning syndrome may arise through different mosaic RASopathies, and 
the presenting PA in our patient may be associated with Schimmelpenning syndrome independent 
of a HRAS or KRAS mutation. A recent case report identified a 4-month-old patient diagnosed 
with Schimmelpenning syndrome resulting from a postzygotic NRAS mutation, although no PA 
was reported (Kuroda et al., 2015). Despite the rare incidence of Schimmelpenning syndrome 
patients developing astrocytomas, it is possible that these individuals have a predisposition to 
develop pro-oncogenic extracutaneous mutations. The strong association between HRAS and 
KRAS mutations in Schimmelpenning syndrome patients and lack of PA suggests a potential 
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common signaling pathway in RASopathy, as defects in other genes regulating the RAS signaling 
pathway also results in an increased incidence of intracranial neoplastic involvement (Canyigit and 
Oguz, 2006; Helfferich et al., 2016; Listernick et al., 2007; Watanabe et al., 2016). Therefore, 
future studies will be needed to determine the convergence or involvement of different 
RASopathies that ultimately give rise to the intracranial tumors mentioned in Table 1. Whether 
the PAs in Schimmelpenning syndrome patients exhibit a more benign development compared to 
those with sporadic PA, as the optic gliomas do, remains to be determined. 
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